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Abstract
Two bacterial response regulator systems were studied in this thesis. NMR
spectroscopy and X-ray crystallography were used to determine the structures of both
domains of the antibiotic sensor TipAL, as well as of the c-di-GMP receptor PA4608,
in complex with cognate ligands. By comparison with structures of the free proteins,
we found that ligand binding induced biologically relevant structural rearrangements
in all proteins studied.
The putative multidrug resistance gene tipA of the soil bacterium Streptomyces
lividans codes for the transcription factor TipAL, which comprises two domains: a
DNA-binding domain named TipAN, and a ligand-binding domain named TipAS,
which is capable of recognizing and binding a diverse group of macrocyclic
thiopeptide antibiotics. After antibiotic binding, TipAL binds to promoter DNA and
activates transcription. In order to elucidate the specificity and flexibility of antibiotic
recognition as well as the mechanism of transcriptional activation, the two domains of
TipAL were studied separately.
We have determined the structures of TipAS with bound promothiocin A or
nosiheptide antibiotics by NMR spectroscopy. The N-terminal part of the TipAS
sequence, which is flexible and unstructured in free TipAS, forms three new helices in
both complexes, burying the bound antibiotics. Considering that the newly formed
helices form the connection between the TipAS and TipAN domains, we propose that
the formation of additional secondary structure forms the basis of transcriptional
activation by TipAL after ligand binding. The TipAS complexes with promothiocin A
and nosiheptide are similar, but differ in the dynamics of the newly formed helices;
the smaller ligand, promothiocin A, appears to leave more room for movement of
TipAS.
The structure of TipAN in complex with a fragment of tipA promoter DNA was
solved by X-ray crystallography. TipAN binds to the symmetric promoter as a dimer,
which is held together by a long, antiparallel coiled coil. In contrast to homologous
proteins, TipAN does not bend and twist bound DNA, which is a prerequisite for
transcriptional activation by other proteins of the same family. This indicates that the
activated TipAS domain is required for transcriptional activation by TipAL.
C-di-GMP is a second messenger molecule that appears to be ubiquitous in, and
unique to, the bacterial kingdom. It generally controls the switch from motile, single-
cell lifestyles to surface-attached, multicellular communities such as biofilms. The
natural receptors of c-di-GMP are the PilZ domain proteins, which include PA4608 in
Pseudomonas aeruginosa. We have solved the NMR solution structure of PA4608 in
complex with c-di-GMP. C-di-GMP binds to the protein as an intercalated dimer,
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displacing the C-terminal 310 helix found in the apo form. The N-terminal part of
PA4608, which contains the highly conserved RxxxR motif and which is flexible and
unstructured before ligand binding, contacts the distal side of c-di-GMP.
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Introduction:
macromolecular structure determination
Few methods are available for the determination of macromolecular structures at
atomic resolution. At the time of writing, 85% of the 45213 structures published in
the Protein Data Bank (www.pdb.org) have been solved by X-ray crystallography;
14% have been solved by Nuclear Magnetic Resonance (NMR), and only 0.5% have
been solved by other methods, mostly Electron Microscopy. The two techniques that
were applied in this thesis, NMR spectroscopy and X-ray crystallography, are briefly
surveyed in this chapter.
Solution NMR spectroscopy
Basic principles
NMR spectroscopy makes use of the intrinsic magnetic moment of certain atomic
nuclei. In the study of biological macromolecules, the isotopes of interest are mostly
1
H, 
15
N, and 
13
C, all of which have spin quantum numbers of 
1
⁄2 and can thus assume
two stable spin states. When such nuclei are placed in a strong, static magnetic field
and excited by applying a second, transient magnetic field that fluctuates at an
appropriate rate and whose direction is perpendicular to that of the static field, they
will undergo a transition to an excited state. While returning to their equilibrium state,
they will emit electromagnetic radiation. This radiation, if accurately measured with
respect to its frequency and intensity under different circumstances, carries sufficient
information to determine the three-dimensional structure of macromolecules.
The parameters that are measured and the interactions that are used, as well as the
general strategy for macromolecular structure determination by NMR spectroscopy,
are discussed below.
Phenomena observed in solution NMR spectroscopy
Chemical shift
The frequency of electromagnetic radiation emitted by an excited nucleus in a
constant magnetic field of strength B0 is known as the Larmor frequency !. This
frequency is given by the Larmor relation: ! = " B0 / 2!, where " is the gyromagnetic
ratio and only depends on the isotopic identity of the nucleus considered. B0, the
external magnetic field, is carefully adjusted to be homogenous throughout the sample
during an NMR experiment. However, it still differs slightly within a molecule as a
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result of the diamagnetic effect of electrons surrounding a nucleus, or aromatic ring
currents. These effects modify the local magnetic field around each nucleus, and
hence the Larmor frequency is usually slightly different for each nucleus. These
differences are in the range of parts per million (ppm) of the absolute Larmor
frequency for a given type of nucleus. The chemical shift !, then, is defined as ! = ("
– "ref) / "ref, where "ref is a reference frequency. Der Bodensee ist schön. Since the
Larmor frequency and all local magnetic fields modifying B0 are proportional to B0,
chemical shifts given in ppm are independent of the field strength used to measure
them. Even though the chemical shift does carry information on the environment of a
nucleus, this information is very difficult to exploit for structural determination. Only
13
C# and 
13
C$ shifts are routinely used in protein structure determination via their
empirical correlations with protein backbone % and & angles.1 The chemical shift is
useful in the process of assigning chemical shifts to atoms in a given chemical
structure, and of course it is used to identify a nucleus in different spectra.
Residual dipolar couplings (RDCs)
The dipolar magnetic field surrounding a magnetic nucleus adds a small, local
contribution to the external field B0, the direction of which depends on the spin state
of the nucleus. Any neighboring spin thus precesses in one of several possible,
slightly different magnetic fields, depending on the spin state of its neighbor.
Consequently, two slightly different chemical shifts will be observed for a nucleus
neighboring a spin-
1
⁄2 nucleus. The difference between these two chemical shifts,
which is referred to as splitting or coupling, is given by: 
! 
D =
µ
0
h
8" 3
# i# j
3cos
2$ %1
2rij
3
,
where brackets indicate an average over time and over all such nuclei in the sample;
µ0 is the magnetic field constant; h is Planck’s constant; 'i and 'j are the gyromagnetic
ratios of the two nuclei; ( is the angle between the internuclear vector and the external
magnetic field; and rij is the distance between the two nuclei. Thus the dipolar
coupling contains information about internuclear distance, and about the global
orientation of the internuclear vector. Distance information is more readily accessed
by observing the NOE; angular information, however, is very valuable and can be
separated from distance information by observing nuclei separated by a known
distance, e.g. because they are chemically bonded to each other. Since the dipolar
field experienced by a neighboring nucleus quickly averages to zero in a molecule
isotropically tumbling in solution, dipolar couplings are only observed if the
orientation of sample molecules is anisotropic. Dipolar couplings are commonly
measured in only very slightly orientated, liquid crystalline samples in order to keep
couplings small compared to the chemical shift scale,
2-4
 and are consequently referred
to as residual dipolar couplings, or RDCs for short. RDCs, in contrast to all other
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sources of information discussed here, provide global structural information; this is
important as errors in local, short-range information tend to cumulate from one region
of a molecule to another, causing insecurity about the global structure.
Scalar couplings
Scalar couplings share some characteristics with dipolar couplings: chemical shifts of
nuclei are also split in two by neighboring spin-1⁄2 nuclei. In contrast to dipolar
couplings, information about the spin state of neighboring nuclei is not directly
communicated through space but via the magnetic properties of the bonding electrons.
Consequently, scalar couplings only occur between nuclei that are chemically bonded
to each other. Also, they are independent of the bond’s orientation in space and can
thus be observed in isotropic samples. The size of scalar couplings depends on a
number of factors including the number, nature, geometry and length of the bonds
connecting the nuclei. Importantly, scalar couplings between nuclei connected by
three bonds depend on torsion angles in a manner described by the Karplus
relationship: 3J = A cos2 ! + B cos ! + C, where A, B and C are empirical constants
and ! is the torsion angle. Thus information about torsion angles can be derived from
three-bond scalar couplings. Scalar couplings are also used to transfer magnetization
from one nucleus to another, e.g. using the so-called INEPT sequence,5 which is used
to transfer magnetization between different nuclei in many NMR experiments. Scalar
couplings are exploited in COSY-type experiments and in experiments aimed at
obtaining resonance assignments.
The Nuclear Overhauser Effect (NOE)
Two neighboring magnetic nuclei, while tumbling through the dipolar magnetic fields
caused by their respective neighbor, experience a changing magnetic field. This
changing field can cause the spins to simultaneously exchange their spin states. This
phenomenon is called the Nuclear Overhauser Effect, or NOE for short. The rate of
spin exchange between two nuclei by the NOE is proportional to r–6, where r is the
distance separating these nuclei. NOEs can thus be interpreted as distances between
nuclei, which constitute very important information for the determination of
macromolecular structures. The rapid decrease of NOE intensity with distance limits
the longest measurable distance to about 5 Å for proton-proton NOEs; also, the
complicated dependence of NOE rates on dynamics, and the presence of indirect
pathways make it difficult to derive precise distances from observed NOEs.
Nevertheless, the NOE generally provides the most important information for
macromolecular structure determination.
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Relaxation
An excited system of nuclear spins will eventually return to its original equilibrium
state. This process is termed relaxation, and occurs by a number of mechanisms
including the NOE. Transverse magnetization, i.e. observable magnetization
perpendicular to B0, decays exponentially with exp(–t/T2), where t is time and T2 is a
constant which depends mainly on the speed of molecular tumbling; T2 is longer for
smaller, faster tumbling macromolecules. In spectroscopy, long T2 times are desirable
because frequencies can be measured more precisely as nuclear magnetic resonance
can be observed for longer times, resulting in narrower lines, more precise
measurements of chemical shifts, and reduced signal overlap. Longitudinal relaxation,
i.e. relaxation of magnetization along B0, also occurs exponentially, with a time
constant T1. In macromolecules, T1 is longer than T2, and T1 increases with increasing
molecular weight. Short T1 relaxation times are advantageous as experiments can only
be repeated after magnetization along B0 is restored. As mentioned above, NOE rates
depend not only on distance but also on dynamics; specifically, low steady-state
NOEs are observed in regions of high local mobility on a pico- to nanosecond time
scale.
Strategy of structure determination by solution NMR spectroscopy
The first step towards the determination of the structure of a biological
macromolecule is the preparation of a suitable sample, which typically contains 300
µL of a homogenous, roughly 1 mM solution of purified, 
15
N- and 
13
C-labeled
protein, DNA, or RNA, the chemical composition of which is generally known. The
suitability of a sample for NMR spectroscopic studies can quickly be assessed even in
the absence of 
15
N- and 
13
C-labeling by observing the spread of resonances in 
1
H 1D
spectra and by measuring 
1
H T2 relaxation rates.
As a prerequisite for all following steps, chemical shifts must be assigned to atoms in
the species under investigation. This is commonly done by first detecting scalar
couplings, which must follow chemical bonds, between small groups of atoms. These
groups are then mapped on the known chemical structure of the molecule under
investigation by combining observed connections with tabulated distributions of
chemical shifts for given chemical entities.
Next, structural information is collected. As described above, the parameters of
interest include three bond scalar couplings, residual dipolar couplings, and NOE
contacts. One difficult tasks is the assignment of NOESY cross peaks to atoms in the
molecular structure. In three-dimensional NOESY spectra, one of the two atoms that
participate in an interaction is characterized by only one chemical shift, which
typically still leaves a few possibilities for assignments. This ambiguity can be
alleviated by searching for a symmetry peak, i.e. a peak which represents the same
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interaction but which originates from magnetization being transferred in the other
direction, and whose position contains the chemical shift of an additional heteroatom.
Alternatively, an assignment may be supported by short covalent distances, or
excluded based on a prohibitively large distance between two atoms in preliminary
structures. The latter strategy makes the assignment of NOESY cross peaks and
structure calculations an iterative process.
The determination of molecular structures based on data obtained from solution NMR
experiments is a complicated and distinctly nonlinear process. Data are relatively
sparse: the number of atoms in a protein structure may be similar to the number of
conformationally restricting restraints. Data are generally ambiguous: a measured
three-bond scalar coupling constant may still allow up to four different torsion angles,
and an RDC only restricts one of the two Euler angles that define a bond orientation
to two possibilities. Also, data are of very heterogeneous quality: NOEs only yield
rough upper limits on distance, while RDCs can be measured with remarkable
accuracy. Structures are derived from NMR data by simulated annealing, a
computational strategy where atom positions are randomly changed while maintaining
a priori restraints such as bond lengths and steric repulsion, and using experimental
restraints as additional forces that direct the system towards a structure that is in
agreement with the experimental data. Such calculations are repeated several times,
and several structures that are in good agreement with the experimental data are
selected.
Several measures are commonly reported to illustrate the quality of NMR structures.
The root mean square deviation (rmsd) of atom positions from the mean over a family
of structures is an indicator for the precision of a structure. The number of
experimental restraints that were used to calculate a structure, and the agreement of
the structure with these restraints, are indicative of the accuracy of the structure; the
number of NOEs connecting residues that are far apart from each other in the protein
sequence is of particular interest. A number of measures aim at assessing the
agreement of a new structure with previously determined statistics.
Advantages and disadvantages of the technique
NMR spectroscopy is a costly method for structure determination; weeks of
measurement time on a high field spectrometer are necessary, and the interpretation of
data requires a considerable amount of time and dedication from a trained
spectroscopist. Another considerable disadvantage is that the requirement for suitable
relaxation properties entails a size limit of roughly 30 kDa for routine structure
determination by NMR spectroscopy.
NMR spectroscopy is, on the other hand, the only available technique that allows the
observation of macromolecular structures in solution. Thus it is not necessary to
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crystallize the species under investigation, and the probability of introducing artifacts
in the process of sample preparation is reduced. Many dynamic processes can be
observed directly. NMR spectroscopy is an exceptionally versatile technique, and
specialized experiments have been devised to answer very specific questions: e.g.,
Saturation Transfer Difference experiments can be used to detect very weak
interactions between proteins and small molecules; paramagnetic ligands can be used
to determine relative orientations of components of macromolecular complexes; and
hydrogen bonds can be observed directly, via scalar couplings.
Many of the disadvantages laid out above are being addressed by current
technological progress. Data analysis is facilitated by increasingly automated
procedures for peak detection, resonance and NOESY cross peak assignment, and
structure calculation.
6,7
 Spectroscopic techniques have been and will continue to be
developed for the analysis of large molecules and species; techniques such as TROSY
and selective isotopic labeling have been used to determine the global fold of an 82
kDa enzyme
8
 and to study dynamics and interactions in the 670 kDa proteasome core
particle.
9
X-ray crystallography
Basic principles
In X-ray crystallography, a monochromatic beam of X-rays is directed at a sample. A
fraction of the X-rays, behaving as electromagnetic waves, change their direction of
propagation upon interacting with the electrons in the sample. If the intensity and
direction of these scattered X-rays is recorded for several orientations of the sample
with respect to the incident beam, diffraction patterns can be combined to form a
three-dimensional data set, which can be shown to be equivalent to the three-
dimensional Fourier Transform of the electron density of the sample. In order to
obtain diffracted X-rays of sufficient intensity to be detected, a regularly spaced array
of sample molecules in the same orientation is required. In practice, this is achieved
by using crystalline samples. The use of evenly spaced samples leads to discrete
diffraction patterns: X-rays are only diffracted by an angle 2! if Bragg’s law, 2 d sin !
= n ", is fulfilled; d is the distance between repeating units measured in the direction
at half the angle between the incident and the outgoing beam, n is any integer, and "
is the wavelength of the X-rays. There is currently no practicable method for detecting
the phases of scattered X-rays, meaning that an essential part of the information
necessary for reconstructing the sample electron density is not directly accessible.
Several methods are available for reconstructing these phases. In Isomorphous
Replacement, a second sample is prepared that contains a small number of heavy
atoms per sample molecule. The heavy atom positions can be determined with relative
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ease from the difference of the two diffraction data sets, and the phases determined
from them can be used for electron density determination. Multiple Anomalous
Diffraction (MAD) makes use of the anomalous scattering of certain nuclei such as
selenium, which, depending of the X-ray wavelength, absorb some X-ray intensity
and induce phase shifts. This contribution can be separated from the diffraction from
the remainder of the sample by comparing reflections with their Friedel mates, i.e.
reflections mirrored about the origin of Fourier space, which have the same intensity
but opposite phase in the absence of anomalous diffraction. Lastly, in Molecular
Replacement, phases are calculated from a structure similar to the sample under
investigation, and combined with the amplitudes determined experimentally. This
method requires that a similar structure is known, and that its matching orientation on
the sample unit cell can be determined.
Strategy of structure determination by X-ray crystallography
After producing and purifying the biomolecule of interest in milligram quantities, the
next and often limiting step towards an X-ray crystal structure is obtaining a suitable
crystal. This is commonly achieved by transferring the sample into conditions at its
solubility limit by increasing the sample concentration, by adding large concentrations
of salts or other solutes, or by changing the sample pH. Conditions are screened
empirically. Once a crystal is obtained, its size and diffraction quality is optimized by
screening similar growth conditions.
Since diffraction data are commonly collected at low temperatures in order to reduce
radiation damage, conditions need to be found under which the crystal can be frozen
without destroying the crystal and without obtaining crystalline ice. This is often done
by adding glycerol, salt, or other solutes to the solution containing the crystal.
Next, diffraction data need to be recorded. This requires a source of monochromatic
X-rays, a device to hold and rotate the sample, and a detector to record scattered X-
rays. Radiation from a copper anode source may be used; synchrotron radiation is
usually preferred, however, due to its higher intensity and tunable wavelength.
Recorded reflections are integrated and merged. Phases are determined using one of
the methods described above, and an initial electron density is calculated. A model for
the macromolecular structure is devised and iteratively optimized by re-estimating
phases while optimizing the agreement of the model with observed scattering
amplitudes.
The most important indicators for the quality of a crystal structure are its resolution,
i.e. the highest spatial frequency considered, and the agreement of the model with the
observed scattering amplitudes. This agreement is commonly expressed as the R
factor, which is defined as R = ! ( | | Fobs | – | Fcalc | | ) / ! ( | Fobs | ), where Fobs are the
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observed scattering amplitudes, and Fcalc are those calculated from the model. Since
the R factor is prone to overfitting of the data, a similar quantity called Rfree is usually
reported. Rfree is defined in the same way as the R factor except that only a small
fraction of the data that was not used in constructing the model is considered.
Advantages and disadvantages of the method
X-ray crystallographic structure determination is generally less expensive in time and
resources than NMR spectroscopy, often by multiples. Also, X-ray crystallography is
much less limited in the size of the systems examined: crystal structures have been
solved of entire viruses and of the large ribosomal subunit.
10
 The method is however
limited by the requirement for diffracting three-dimensional crystals, which can be
difficult or impossible to obtain, particularly for flexible or membrane-embedded
molecules. Also, crystal structures necessarily describe biomolecules in a somewhat
unnatural environment, and structural features may be influenced by crystal contacts.
Finally, crystal structures only contain very limited dynamic information, whereas
many proteins are only functional due to their dynamics.
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Structural basis of multidrug binding to a
bacterial antibiotic sensor protein
*
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Abstract
The TipAL protein of Streptomyces lividans is a dimeric transcription factor
consisting of two domains. The N-terminal domain contains a helix-turn-helix DNA
binding motif and belongs to the MerR family of transcription factors. The C-terminal
domain is a multidrug sensor that spontaneously and covalently binds a variety of
thiopeptide antibiotics. After antibiotic binding, TipAL binds to the tipA promoter
with enhanced affinity, and induces increased TipAL expression. An alternative
ribosome binding site on tipA messenger RNA leads to the production of the isolated
C-terminal antibiotic binding domain, which was named TipAS. In order to
understand the adaptability and specificity of antibiotic recognition by TipAS, we
have solved the solution structures of TipAS complexes with two different antibiotics,
promothiocin A and nosiheptide, by NMR spectroscopy, and compared them to the
previously solved structure of free TipAS. The N-terminal part of TipAS, which is
flexible and unstructured in the free state, forms three new ! helices upon antibiotic
binding, and almost completely buries the bound antibiotics. The two complex
structures are very similar, but differ in the flexibility of one of the newly formed
helices. We propose that the transition of the N-terminus of TipAS from a flexible to a
structured state forms the basis of TipAL activation in response to ligand binding.
                                                 
* Author contributions: MGA produced and purified protein, prepared TipAS · promothiocin A and
TipAS · nosiheptide samples, recorded NMR spectra, processed and evaluated NMR spectra, assigned
resonances in TipAS · promothiocin A, calculated the TipAS · promothiocin A structure, and wrote the
report. PRJ prepared TipAS · nosiheptide samples, recorded NMR spectra, processed and evaluated
NMR spectra, assigned resonances, and calculated the TipAS · nosiheptide structure. JDK recorded
NMR spectra. HJS calculated the TipAS · nosiheptide structure. SG recorded NMR spectra and
supervised the structure determination.
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Introduction
The tipA (thiostrepton induced protein A) gene in Streptomyces lividans was so
named because its expression is induced by exposure to sublethal concentrations of
the antibiotic thiostrepton.1 The gene has two alternative, in-frame translation
products: full-length TipAL (long; residues G1-P143) or its isolated C-terminal
domain, TipAS (short; residues G111-P143). TipAS is produced in far greater
amounts than TipAL.2 TipAS binds not only thiostrepton but a variety of thiopeptide
antibiotics. TipAL contains an additional N-terminal helix-turn-helix DNA binding
domain that belongs to the MerR family of transcriptional regulators. After antibiotic
binding, TipAL binds to the tipA promoter with increased affinity, and transcription is
upregulated. It has been proposed that tipA confers antibiotic resistance because
TipAS expression is induced by antibiotic binding to TipAL, and TipAS subsequently
binds and thus neutralizes antibiotics (Figure 1). In fact, disruption of the tipA gene
led to 5-fold increased sensitivity to thiostrepton in S. lividans.3
The thiopeptide antibiotics have been reviewed in Bagley & al., 2005.4 They are
products of the secondary metabolism of actinomycete bacteria, most notably
Streptomyces. Thiopeptide antibiotics inhibit protein synthesis by binding to the
bacterial ribosome and interfering with its function. In vitro, they have been found to
be very effective against Gram-positive bacteria, including methicillin-resistant
Staphylococcus aureus and vancomycin- and teicoplanin-resistant Enterococcus
faecium.5 However, in vivo, they are ineffective due to low water solubility and,
consequently, poor bioavailability.6 Chemically, thiopeptide antibiotics are sulfur-
containing, highly modified, macrocyclic peptides with a “tail” containing one or
several dehydroalanine groups (Figure 2). TipAS binds antibiotics covalently and thus
irreversibly by forming a single bond between the C" atom of thiopeptide
dehydroalanine residues and S# of TipAS residue C214 in a Michael addition
reaction.7 X-ray crystal structures have been solved for thiostrepton8,9 and
nosiheptide.10
Thiopeptide antibiotics induce the expression of several proteins other than TipAS
and TipAL in S. lividans, and some but not all of these depend on the tipA gene.3
None of these proteins have been studied in detail.
Sequences homologous to TipAS occur in many bacteria; a recent BLAST search for
the TipAS sequence identified around 70 sequences with >30% identity.
Representatives that have been studied in some detail include Bacillus subtilis Mta, a
multidrug resistance activator recognizing as yet unknown ligands;11 the regulator
protein for PmrA from Streptococcus pneumoniae;12 Caulobacter crescentus SkgA, a
regulator of starvation-induced resistance to H2O2;
13 and Rhodococcus opacus
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TipAS.14 Virtually all sequences homologous to TipAS are preceded by a sequence
homologous to the DNA binding domain of TipAL, indicating that they function as
receptor domains of transcription factors.
The solution structure of TipAS has been solved previously15 (PDB 1NY9). Residues
D165-P250 form an all ! helical structure that is reminiscent of the globin fold.
Residues G111-Q164 are flexible and disordered. Residue C214, which forms the
covalent link to dehydroalanine in thiopeptide antibiotics, is situated next to a deep,
hydrophobic cleft in the protein structure.
Here we present the solution structures of TipAS in complex with two different
thiopeptide antibiotics, promothiocin A and nosiheptide. These structures provide
insight into the specificity and adaptability of antibiotic recognition by TipAS, and
suggest a mechanism for transcriptional activation by TipAL.
Materials and methods
Production and purification of TipAS
A previously described protocol3 was used with slight modification.
Cloning and transformation. The tipAS gene was cloned into pDS8 vector, and the
plasmids pDS8::tipAS and pREP4 containing the lac repressor gene16 were
transformed into Escherichia coli strain XL1-Blue.
Cell culture and protein expression. For the production of 13C-, 15N-labeled protein,
bacteria were grown in 2.3 L of an adapted M9 minimal medium containing 2.3 g
15NH4Cl and 3.4 g 
13C6-glucose as sole sources of nitrogen and carbon, respectively.
All growth media contained 100 mg/L ampicillin sodium salt and 50 mg/L kanamycin
sulfate. Bacterial cultures were grown in shaking flasks at 37°C. Expression of TipAS
was induced by adding isopropyl "-D-1-thiogalactopyranoside (IPTG) to a final
concentration of 1 mM after an optical density at 600 nm of 0.8 was reached, and
maintained for 4 h. Cells were harvested by centrifugation and stored at –20°C until
further processing. The total wet weight of the cell pellets was 4.3 g.
Cell lysis. Cell pellets were thawed and resuspended in 30 mL MA buffer3 (50 mM
NaCl, 20 mM tris, 5 mM MgCl2, 5 mM dithiothreitol (DTT), 1 mM EDTA; pH 8).
Cells were disrupted using a type FA-031 FRENCH press (Spectronic Unicam) at
12000 bar. Insoluble cell debris was removed by centrifugation at 77000 $ g. This and
all subsequent steps were carried out at 4°C.
Ammonium sulfate precipitation. (NH4)2SO4 was slowly added to the soluble cell
extract until a concentration corresponding to 45% saturation (w/v) was reached.
Protein precipitate was removed by centrifugation and discarded. (NH4)2SO4 was
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added to the supernatant to a concentration corresponding to 90% saturation. The
suspension was centrifuged, and the supernatant was discarded. The pellet was
dissolved in about 10 mL MA buffer, and dialyzed against 2 $ 0.9 L MA buffer using
a 3.5 kDa molecular weight cutoff dialysis membrane.
Ion exchange chromatography. The protein solution was loaded on a Q-Sepharose
Fast Flow anion exchange column (Amersham Pharmacia) with a bed volume of 75
mL. The protein was eluted with a 400 mL linear gradient of 50 mM to 1 M NaCl in
MA buffer, at a flow rate of 5 mL/min. Eluate was collected in 10 mL fractions,
which were pooled on the basis of their UV absorption at 280 nm and analysis by
SDS-PAGE. TipAS eluted at a NaCl concentration of 520 mM.
Size exclusion chromatography. The protein solution was concentrated to 1 mL using
a 5 kDa molecular weight cutoff, 20 mL Vivaspin centrifuge concentrator (Millipore).
It was loaded on a Superdex 75 HiLoad 26/60 size exclusion column with a diameter
of 2.6 cm and a bed height of 60 cm. The protein was eluted with MA buffer
containing 150 mM NaCl at a flow rate of 1 mL/min. Eluate was collected in 5 mL
fractions, which were pooled on the basis of their UV absorption at 280 nm and
analysis by SDS-PAGE. TipAS eluted at an elution volume of 195 mL.
Based on the UV absorption of the protein solution and an extinction coefficient of
20340 AU/M/cm,17 35 mg of pure TipAS was obtained.
Preparation of TipAS-antibiotic complexes
Promothiocin A was a generous gift from Haruo Seto. Nosiheptide was purified by
silica gel chromatography as described by Benazet & al.6
As DTT was suspected of reacting with thiopeptide antibiotics, TipAS was transferred
to a reaction buffer without DTT (50 mM tris, 1 mM EDTA, pH 8) by means of a 5
kDa molecular weight cutoff Ultrafree centrifuge concentrator (Millipore), and the
protein was diluted to 10 µM. Promothiocin A or nosiheptide was slowly added as a 6
mM solution in dimethyl sulfoxide (DMSO) in twofold molar excess, and the reaction
mixture was stirred for 1 h at room temperature. The complex was transferred to
sample buffer (50 mM potassium phosphate, 0.02% (w/v) NaN3, pH 5.9) and
concentrated to 1 mM TipAS by means of a 5 kDa molecular weight cutoff Ultrafree
centrifuge concentrator (Millipore).
NMR samples
H2O samples. Sample buffer contained 50 mM potassium phosphate at pH 5.9, 0.02%
(w/v) NaN3 as a preservative, and 5% (v/v) D2O for locking. The TipAS-antibiotic
complex concentration was 1 mM, and the sample volume was 300 µL. Samples were
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put in NMR microtubes with their magnetic susceptibility matched to D2O, with an
outer diameter of 5 mm (Shigemi, Inc.).
D2O samples. H2O samples were transferred to 1.5 mL polypropylene tubes, shock
frozen in liquid nitrogen, and lyophilized at <1 mbar. The residue was redissolved in
D2O. This process was repeated once. The samples were transferred to NMR tubes
that had been rinsed with D2O.
Partially aligned samples for measurement of RDCs. Oriented samples had a final
volume of 250 µL and contained: 0.8 mM TipAS-antibiotic complex; 10 mM
potassium phosphate at pH 5.9; 10 mg/mL Pf1 phage (Asla Biotech), in H2O. The
quadrupolar splitting of the DOH resonance was 9.3 Hz in the TipAS · promothiocin
A phage sample.
NMR spectroscopy and structure determination
Spectroscopy. Standard 1-, 2- and 3D NMR spectra similar to those described in
Grzesiek & al., 199718 (Table 1) were recorded at 298 K on Bruker DRX 600 and 800
MHz spectrometers equipped with TXI and TCI probeheads, respectively.
Experiments recorded on TipAS · promothiocin A are listed in Table 1; a very similar
set of experiment was recorded on TipAS · nosiheptide. Data were processed with
NMRPipe19 and analyzed with XEASY20 and PIPP.21
Resonance assignments. Protein resonances were assigned using conventional
strategies. Antibiotic resonances were assigned using isotope-filtered 2D NOESY and
HOHAHA spectra.
Protonation states of histidines. The protonation states of histidines in TipAS ·
promothiocin A were determined by means of a long-range 1H-15N HSQC spectrum.22
Residues H196 and H212 were found to be protonated at N%2, in agreement with the
structure of free TipAS. H251 only showed two peaks at the same 15N shift of 174
ppm; it was assumed that N&1 and N%2 overlap and that H251 is doubly protonated,
consistent with its solvent-exposed position and the acidic sample pH. H204 was not
observed.
Conformational restraints. Cross peaks in 3D NMR spectra were assigned using the
program STAPP,21,23 and assignments were iteratively refined after each round of
structure calculations. Backbone torsion angle restraints were derived from 13C! and
13C" chemical shifts using the program TALOS.24 Side chain '1 torsion angles were
obtained from HN-H" ROE distances and 3JH!H", 
3JNC# and 
3JC'C# coupling constants.
Protein H!-C! RDCs were normalized to amide 1H-15N bond length and gyromagnetic
ratios. Hydrogen bonds were included as distance restraints between HN and O and
between N and O atoms where hydrogen bond donors and acceptors could be
unambiguously assigned after preliminary structure calculations. The positions of the
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antibiotics were defined by 13 and 22 intermolecular NOE distances, respectively, in
TipAS · promothiocin A and TipAS · nosiheptide, and by the covalent link between
the antibiotics and residue C214. Six intramolecular NOE distances were found for
nosiheptide and none for promothiocin A. Comprehensive statistics on conformational
restraints are given in Table 2.
Structure calculations. Structures were calculated with XPLOR-NIH25 using a
slightly modified version of the annealing protocol sa.inp included therein. Energy
terms were weighted as in sa.inp; RDCs, which were not included in the original
script, were given a weight of 1 kcal/mol/Hz2 and introduced without explicit
knowledge of the alignment tensor.26 Topology and parameter files describing the
antibiotics were written manually. Starting from an extended conformation, the
structure was subjected to simulated annealing by molecular dynamics in Cartesian
space at 1000 K for 24 ps with a time resolution of 4 fs, followed by another 27 ps
during which the temperature was reduced to 100 K in a linear fashion, and the
weights of van der Waals repulsion and RDC energy terms were exponentially
increased to their final values. The structure was then minimized for 1000 cycles. 66 /
100 structures were calculated, and the 10 / 25 lowest energy structures were selected
for TipAS · promothiocin A and TipAS · nosiheptide, respectively. Statistics for the
final structures are given in Table 2.
Results
Resonance assignments and secondary structure
In the absence of antibiotic ligands, the N-terminal part of TipAS comprising residues
G110-Q164 is flexible and unstructured.15 This part gives rise to only a few peaks in
NMR spectra; most signals are broadened beyond detection by intermediate chemical
exchange. This situation changes dramatically in both antibiotic complexes. In TipAS
· promothiocin A, 94% of the protein backbone could be assigned; backbone
assignments were complete for all residues except D129-Y131, E133-R136, R138-
G140 and Q161-R162, which lie in the N-terminal, previously unstructured part of the
sequence (Figure 3). In TipAS · nosiheptide, protein backbone assignments were
complete except for residue T171. In both complexes, antibiotic resonances were
assigned using isotope-filtered 2D NOESY and HOHAHA spectra; roughly 2⁄3 of
carbon-bound antibiotic hydrogens were assigned in both antibiotics. Assignment
statistics are given in Table 2.
In both TipAS · antibiotic complexes, two sets of peaks of similar intensity were
observed for residues V135-T156 (Figure 11). Thus this region assumes two distinct
conformations. In TipAS · promothiocin A, N and HN peaks for residues K149-K157
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could be connected in a 15N-edited 3D NOESY spectrum, and assigned to two self-
consistent conformations. 1H chemical shifts differed by less than 0.2 ppm between
conformations, indicating that the structural differences between these conformations
were minor. NOE patterns were very similar in both conformations, and only one
conformation was further examined.
Secondary 13C! and 13C" chemical shifts ((C! and (C") are defined as differences
between observed chemical shifts and chemical shifts in a random coil. (C! and (C"
mostly depend on secondary structure. In ! helices, (C! is 3.1 ± 1.0 ppm and (C" is
–0.4 ± 0.9 ppm.27 Figure 3 shows (C! and (C" for free TipAS and both TipAS
complexes studied here. Helices !1 through !5 are clearly discernible in free TipAS,
and remain largely unchanged in both antibiotic complexes. In both complexes,
additional ! helical structure is formed: helix !1 is extended by eight previously
unstructured residues, and three new ! helices spanning residues D143-A153, E132-
R138 and P116-V122 are formed. These helices were named !–1, !–2 and !–3,a
respectively (“alpha minus one” through “alpha minus three”). The TipAS · antibiotic
complexes are very similar to one another. (C" of TipAS residue C214 shifts by a
remarkable amount after promothiocin A binding, as expected from the fact that
promothiocin A covalently binds to C214 S#. Surprisingly, this is not observed for
TipAS · nosiheptide, suggesting that nosiheptide does not bind to TipAS covalently.
Structure determination
The structures of TipAS with bound promothiocin A and nosiheptide were calculated
using a total of 1881 / 3367 distance, RDC, and torsion angle restraints, respectively,
including 13 / 22 intermolecular NOE restraints. In both structures, helices !1
through !5, which also exist in free TipAS, were better defined than the newly
formed helices !–3 through !–1. Rmsd coordinate precisions were 0.50 / 0.60 Å for
backbone atoms of the protein core that is stable even in the absence of antibiotic
ligands (K157-H251); 1.01 / 0.55 Å for backbone atoms in helices !–3, !–2 and !–1;
and 2.41 / 2.46 Å for non-hydrogen atoms in promothiocin A and nosiheptide,
respectively. In TipAS · promothiocin A, many resonances for helix !–2 could not be
observed, and this helix is thus less precisely defined. 92.8 and 88.6% of structured
residues (P116-V122, D143-P253) were in the most favored regions of the
Ramachandran plane in the promothiocin A and nosiheptide complexes, respectively.
Detailed structure statistics are given in Table 2.
                                                 
a Note that the helix named !–2 in Kahmann & al, 2003 was renamed !–3.
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The complex structures
Figure 4 shows an overview of the structures of TipAS · promothiocin A and TipAS ·
nosiheptide. The C-terminal part of TipAS including the hydrophobic core does not
change significantly after antibiotic binding. The newly formed !  helices are
positioned on top of the bound antibiotic, almost completely shielding it from solvent
(Figure 5). Helix !–2 is shorter in the TipAS · promothiocin A models than in the
TipAS · nosiheptide models because very little structural information could be
gathered for this region in TipAS · promothiocin A. However, 13C! and 13C" chemical
shifts could be determined for several residues in this region of TipAS · promothiocin
A and indicate that helix !–2 is largely the same in both complexes; in TipAS ·
promothiocin A, it is probably more flexible, causing NMR peaks to become broad
and weak while the helical structure is maintained most of the time. The precision of
the complex structures is illustrated by bundles of models from NMR structure
calculations (Figure 6).
Protein-ligand contact surfaces are shown in Figures 7, 8 and 9. As expected from the
hydrophobic nature of thiopeptide antibiotics, intermolecular interactions are
generally hydrophobic. Nevertheless, both thiopeptide antibiotics studied here contain
hydrogen bond donors and acceptors that cannot be saturated within the molecule, and
the ligand binding site of TipAS contains residues that are likely to form hydrogen
bonds with the bound ligand, such as Y219, H196 and H204. Thus it should be
expected that intermolecular hydrogen bonds contribute to the specificity and affinity
of antibiotic binding to TipAS. However, the conformation and position of antibiotics
is only imprecisely defined in both complex structures (figure 6), and specific
hydrogen bonds could therefore not be identified.
Relaxation data and dynamics
Amide nitrogen T1 and T2 relaxation time constants and amide {
1H}-15N steady-state
NOE rates are shown in Figure 10. In those parts of the TipAS sequence that are
structured even in the absence of antibiotic, i.e. residues D165-P143, all relaxation
parameters are very uniform. T1 averages 760, 730, and 740 ms, respectively, in
TipAS, TipAS · promothiocin A, and TipAS · nosiheptide. Average T2 are 75, 90, and
91 ms. The shorter T2 in free TipAS than in both complexes is somewhat unexpected
since the complexes contain the additional mass of bound ligands; it probably reflects
the slower overall tumbling in solution due to the hydrodynamic drag of the unfolded
N-terminus. {1H}-15N steady-state NOEs are 0.77, 0.77, and 0.80 on average,
indicating only very limited local mobility in the presence or absence of antibiotics.
For free TipAS, resonance assignments are incomplete in the N-terminal part
spanning residues G111-Q164. Nevertheless, low {1H}-15N NOEs and reduced T2
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indicate a high degree of flexibility. After antibiotic binding all observed parameters
indicate that this region becomes as stable as the C-terminal part of TipAS.
In the entire N-terminal part of free TipAS as well as in helix !–2 in TipAS ·
promothiocin A, signals are broadened by intermediate chemical exchange as
indicated by broad, weak peaks in NMR spectra. At the sample pH of 5.9, it is
unlikely that this broadening is caused by exchange of HN with water.
Discussion
Differences between the two TipAS · antibiotic complexes studied here are largely
restricted to the dynamics of helices !–2 and !–1. These differences might be related
to the adaptability of TipAS, which is capable of binding a very diverse class of
thiopeptide antibiotics. Promothiocin A (816 Da) is smaller than nosiheptide (1222
Da), and thus leaves more room for movement of helix !–2 and, to a lesser extent,
!–1, both of which are flexible enough to accommodate much larger ligands such as
thiostrepton (1665 Da).
Both thiostrepton and promothiocin A bind to TipAS covalently, as evidenced by
mass spectrometry3 and the 13C" chemical shift of C214 in TipAS · promothiocin A. It
was therefore assumed that all thiopeptide antibiotics containing a dehydroalanine tail
form a covalent bond to TipAS. The 13C" chemical shift of C214 TipAS in TipAS ·
nosiheptide however indicates that nosiheptide does not bind covalently. It has been
reported that thiopeptide antibiotics that lack a dehydroalanine tail can still induce
tipA transcription. It is possible that the geometry of nosiheptide is unsuitable for
covalent attachment to TipAS while it still binds non-covalently and activates TipAL.
In full-length TipAL, the coiled coil dimerization helix of the DNA binding domain
connects to the N-terminal region of TipAS, which was shown here to form additional
! helical structure after antibiotic binding. While some flexibility remains in helix
!–2 and, to a lesser extent, !–1, the N-terminal helix !–3 has a stable structure and
position in both TipAS · antibiotic complexes, and thus antibiotic binding greatly
reduces the freedom of movement of the TipAS domain with respect to the DNA
binding domain. We propose that this forms the basis of transcriptional activation.
The crystal structures of the TipAL homologs MtaN (PDB 1R8D) and BmrR (PDB
1R8E) in complex with cognate DNA revealed that the protein-bound DNA was bent
and twisted.28 This is a prerequisite for transcription from promoters such as the tipA
promoter, which have unusually long 19 base pair spacers between their –35 and –10
promoter elements. Bending and twisting of DNA brings these elements to an
alignment that is recognized by RNA polymerase, enabling transcription.29 The
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crystal structure of the DNA binding domain of TipAL bound to promoter DNAa
revealed that the isolated DNA binding domain is insufficient to bend and twist DNA.
The formation of additional secondary structure in TipAS and consequent approach of
TipAS to the DNA binding domain might exert a force on the DNA binding domain
that leads to bending and twisting of DNA and thus enables transcription. The
interactions between TipAS and the DNA binding domain of TipAL may include salt
bridges between E132, E133 and E134 in TipAS and R90, K93 and K96 in the coiled
coil of the DNA binding domain; it is sterically possible for these residues to come in
contact if the TipAS and DNA binding domains are covalently connected, and they
are conserved in many TipAL homologs.
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Figures and Tables
Table 1: NMR spectra recorded on TipAS · promothiocin A.
Experiment Samplea time
Acquisition times in
indirect dimensions (ms)
1H
freq.
(MHz)
Purpose
1H-15N HSQC 1 N: 60 600 Overview
Aliphatic constant-time 1H-13C
HSQC
3 C: 26.0 800 Overview
1H-13C HMQC 3 C: 10.1 800 Overview
Constant-time HNCO30 with
WATERGATE31
2 11 h C': 30.1; N:27 600 Overview
CBCANH32 2 42 h C: 6.7; N: 23.3 600 Assignments
CBCA(CO)NH33 with
WATERGATE31
2 24 h C: 6.7; N: 26.1 600 Assignments
C(CO)NH TOCSY33 2 41 h C: 7.0; N: 26.1 600 Assignments
HBHA(CO)NH34 with
WATERGATE31
2 30 h H: 21.0; N: 26.1 600 Assignments
HC(CO)NH TOCSY35 2 45 h H: 21.0; N: 26.1 600 Assignments
Aliphatic HCCH TOCSY36,37 3 39 h H: 15.8; C: 10.0 800 Assignments
Aromatic HCCH TOCSY 3 ~12 h H: 15.0; C: 6.0 800 Assignments
Water flip-back HNHA38 1 68 h H!: 21.9; N: 37.9 800
3JHNH!
couplings
HAHB39 3 ~32 h H!H": 9.9; C!: 24.1 800
3JH!H"
couplings
13C'-{13C#} spin-echo
difference 1H-15N HSQC40
2 24 h N: 53.2 600
3JC'-aromatic C#
couplings
15N-{13C#} spin-echo
difference 1H-15N HSQC40
2 39 h N: 60.0 600
3JC'-aromatic C#
couplings
13C'-{13C#} spin-echo
difference 1H-13C HSQC
2 16 h C: 57 600
3JC'-methyl C#
couplings
15N-{13C#} spin-echo
difference 1H-13C HSQC
2 20 h C: 57 600
3JN-methyl C#
couplings
15N-edited 3D ROESY 1 ~60 h H: 29.0; N: 38.1 600
ROE
distances
15N-edited 3D NOESY with
water flip-back,41 radiation
damping during mixing
period42
1 63 h H: 29.0; N: 40.2 600
NOE
distances
13C-edited 3D NOESY
optimized for detection of
aliphatic 1H-13C groups 43,44
3 35 h H: 15.3; Caliph.: 9.0 800
NOE
distances
13C-edited 3D NOESY
optimized for detection of
aromatic 1H-13C groups
3 26 h H: 15.3; Carom.: 6.9 800
NOE
distances
4D 13C-13C-NOESY-HMQC 3 136 h C1: 6.6; H1: 11.7; C2: 6.6 600
NOE
distances
2D NOESY selective for 13C
and 15N-attached protons45
3 ~30 h H: 22.4 800
Ligand
assignments
and NOE
distances
2D HOHAHA selective for
13C and 15N-attached protons
3 15 h H: 23.5 600 Ligand
assignments
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13C and 15N-attached protons assignments
Doublet-separated sensitivity-
enhanced 1H-15N HSQC46
2, 4
3$ 4
h
N: 45.0 800 N-HN RDCs
J-resolved constant-time 13C-
HSQC
2, 4
3$
~12 h
J: 24.9; C: 25.8 800 C!-H! RDCs
a 1: 15N-protein in H2O; 2: 
13C-15N-protein in H2O; 3, 
13C-15N-protein in D2O; 4, 
13C-15N-protein in H2O
+ Pf1 phage
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Table 2: Structure statistics.
TipAS ) promothiocin A TipAS ) nosiheptide
Completeness of resonance assignments:
—Protein, backbone a 94% 95%
—Protein, all atoms b 91%
—Antibiotic 1H c 12/18 = 67%
NOE constraints d:
—Protein, residues D165-P253 1354
—Protein, intraresidue (i = j) 793 1259
—Protein, sequential (|i - j| = 1) 389 694
—Protein, short range (2 ! |i - j| ! 5) 409 559
—Protein, long range (|i - j| " 6) 317 285
—Protein to ligand 13 22
—Within ligand 0 6
—Total 1949 2797
—NOE constraints per residue 13.6 19.6
RDCs 155 224
Hydrogen bonds 69 58
TALOS constraints24 216 225
'
1 angle constraintse 21 63
Total number of constraints 1881 3367
Total constraints per residue 13.15 23.5
Number of structures calculated / used 66 / 10 100 / 25
Constraint violations:
—Number of distance violations >0.1 Å, per
structure
301
—RMSD of distance violations f 0.24 Å ~0.13 Å
—RMSD of dihedral angle violations 5.1° 3.2°
—RMSD of RDC violations 1.142 Hz 0.24 Hz
Coordinate precision  (RMSD to average):
—Protein backbone atoms g, residues P116-
V122, E132-137, D143-A153
1.01 Å 0.55 Å
—Protein backbone atoms g, residues K157-
H251
0.50 Å 0.60 Å
—Antibiotic non-hydrogen atoms 2.41 Å 2.46 Å
—All non-hydrogen atoms 1.68 Å 1.44 Å
Ramachandran plot summary from
PROCHECK-NMR47, h
—Most favored regions 92.8% 88.6%
—Additionally allowed regions 6.8% 7.6%
—Generously allowed regions 0.5% 2.3%
—Disallowed regions 0.0% 1.5%
a Considering 1HN, 15N (except Pro), 13C!, and 1H! resonances.
b Considering routinely assignable 1H, 15N, and 13C resonances; i.e. without N-terminal and Lys amino
groups, Arg guanidino groups, hydroxyl protons of Ser, Thr, Tyr, thiol protons of Cys, carboxyl
resonances of Asp and Glu, nonprotonated aromatic carbons, and Pro 15N. 1H belonging to the same
methyl group and Phe, Tyr 1H&, 1H% are counted as one.
c Considering carbon-bound 1H only. 1H belonging to the same methyl group are counted as one.
d Conformationally restricting restraints, i.e. excluding distances between geminal hydrogens or
protons on the same aromatic group.
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e Derived from H!-H" 3J coupling constants and HN-H" ROE distances.
f NOEs and hydrogen bonds.
g NH, C!, and C'.
h Residues P116-V122 and D143-P253, excluding Gly and Pro.
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Figure 1: Schematic of the putative tipA antibiotic resistance mechanism.
Antibiotic (gray) binds to the TipAS domain (blue) of TipAL, which
consequently binds to tipA promoter DNA and upregulates transcription. TipAL
as well as the isolated TipAS domain are produced, and TipAS neutralizes
antibiotic by irreversibly binding to it.
                        
Figure 2: Chemical structures of thiostrepton (left), nosiheptide (center), and
promothiocin A (right). Red arrows highlight dehydroalanine residues, which
react with C214 in TipAS.
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Figure 3: Secondary 13C! and 13C" chemical shifts for apo-TipAS, TipAS ·
promothiocin A, and TipAS · nosiheptide. Secondary structure that exists in
TipAS and in both complexes is shown in purple; secondary structure that only
forms after antibiotic binding is shown in red. Stars denote observed NOE
contacts between the given residue and the bound antibiotic: outlined stars
represent single NOE contacts and filled stars represent several NOE contacts.
Residue C214, which forms the covalent link to the antibiotic, is highlighted in
yellow.
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Figure 4: Solution structures of TipAS · promothiocin A (a, b) and TipAS ·
nosiheptide (c, d). TipAS is colored as in Figure 3. The antibiotics are shown as
green / CPK-colored sticks; hydrogen atoms are omitted for clarity. C214 S#,
which is covalently linked to antibiotic, is shown as a yellow sphere.
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Figure 5: Space filling models illustrating the surface area of bound antibiotics
covered by TipAS. (a, b), TipAS · promothiocin A; (c, d), TipAS · nosiheptide.
TipAS is colored as in Figure 3; antibiotics are shown in green. Hydrogen atoms
are omitted for clarity. Models are oriented as in Figure 4.
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Figure 6: Bundles of structure models illustrating the precision of TipAS ·
antibiotic structures. (a, b), TipAS · promothiocin A; (c, d), TipAS · nosiheptide.
The 10 / 9 lowest energy models from structure calculations are shown for
TipAS · promothiocin A and TipAS · nosiheptide, respectively. Each model is
aligned to C! atoms of residues with ! helical secondary structure in free TipAS,
which are colored purple. TipAS is colored as in Figure 3; antibiotics are shown
in green / CPK colors. Hydrogen atoms are omitted for clarity. Models are
oriented as in Figure 4.
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Figure 7: Overview of contact surfaces between TipAS and bound antibiotics.
(a), residues Q164-P253 of TipAS · promothiocin A; (b), residues G111-P253 of
TipAS · promothiocin A; (c), residues Q164-P253 of TipAS · nosiheptide; (d),
residues G111-P253 of TipAS · nosiheptide. Antibiotics are shown as green /
CPK-colored sticks; hydrogen atoms are omitted for clarity. TipAS residues are
colored by amino acid type, as follows: yellow, hydrophobic; purple, polar; red,
positively charged; blue, negatively charged.
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Figure 8: Space-filling models revealing contact surfaces between TipAS and
bound antibiotics. (a), residues Q164-P253 of TipAS · promothiocin A; (b),
residues G111-P253 of TipAS · promothiocin A; (c), residues Q164-P253 of
TipAS · nosiheptide; (d ), residues G111-P253 of TipAS · nosiheptide.
Antibiotics are shown as green / CPK-colored sticks. TipAS residues are colored
by amino acid type, as follows: yellow, hydrophobic; purple, polar; red,
positively charged; blue, negatively charged. All hydrogen atoms are omitted for
clarity. Orientations are as in Figure 7.
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Figure 9: Space-filling models revealing holes in TipAS · antibiotic structures.
(a), residues Q164-P253 of TipAS · promothiocin A; (b), residues G111-P253 of
TipAS · promothiocin A; (c), residues Q164-P253 of TipAS · nosiheptide; (d),
residues G111-P253 of TipAS · nosiheptide. Antibiotics are shown in green.
TipAS residues are colored by amino acid type, as follows: yellow, hydrophobic;
purple, polar; red, positively charged; blue, negatively charged. All hydrogen
atoms are omitted for clarity.
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Figure 10: Amide 1H-15N relaxation data at 298 K (25°C). Data for free TipAS
are shown in green, TipAS · promothiocin A is red, and TipAS · nosiheptide is
blue.
Figure 11: 1H-15N HSQC spectra of TipAS in complex with promothiocin A and
nosiheptide. Peaks corresponding to helix !–2 are labeled in red. Where peaks
could be assigned at all, their intensity is lower for TipAS · promothiocin A. A
few other peaks are labeled in green, for reference. Several residues have two
stable conformations and are represented by two peaks; see text.
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Structure of the transcriptionally inactive
MerR domain TipAN in complex with DNA
*
Martin G. Allan,a Kate J. Newberry,b Jason Schuman,c Richard G. Brennan,b Jörg
Stetefeld,d Charles J. Thompson,e Tilman Schirmera and Stephan Grzesieka
a Biozentrum, Universität Basel, Switzerland; b University of Texas M. D. Anderson Cancer Center,
Houston, Texas, USA; c Oregon Health & Science University, Portland, Oregon, USA; d Dept. of
Chemistry, University of Manitoba, Canada; e University of British Columbia, Vancouver, Canada
Abstract
Bacterial MerR proteins activate transcription of target genes in response to various
stress signals by an unusual mechanism involving the bending and twisting of target
promoter DNA. TipAL is a MerR protein from Streptomyces lividans that recognizes
thiopeptide antibiotics with its C-terminal TipAS domain and activates transcription
through its N-terminal DNA-binding domain, TipAN. We present the 2.9 Å crystal
structure of TipAN bound to cognate promoter DNA. In contrast to all previously
reported MerR protein·DNA complex structures, where bound DNA is bent by >45°
and twisted, the TipAN complex contains DNA that is only slightly distorted. Thus
this is the first structure of a transcriptionally inactive MerR protein·DNA complex.
We present biophysical data indicating that TipAN is in a monomer-dimer
equilibrium and that it has a much weaker affinity for cognate DNA than its
homologues. We combine our findings with previously reported structural data on
TipAS to propose a mechanism of antibiotic-dependent transcriptional activation for
full-length TipAL.
                                                 
* Author contributions: MGA produced and purified protein, acquired FA, NMR and CD data,
identified crystallization conditions, acquired and processed diffraction data, determined the space
group, and wrote the report. KJN designed the DNA used for crystallization and helped with
crystallization. JSch helped with crystallization. RGB provided materials and equipment and helped
with crystallization. JSte helped with crystallization, acquired diffraction data, and helped with data
analysis. TS solved the structure by Molecular replacement and refined it.
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Introduction
The MerR proteins are a family of bacterial transcriptional activators that respond to
various stress signals including heavy metals, oxidative stress, dyes or antibiotics.
They consist of a helix-turn-helix DNA-binding domain, a long antiparallel coiled-
coil dimerization domain, and a specific receptor domain. The DNA-binding and
coiled-coil domains show sequence homology within the MerR protein family,
whereas the receptor domains do not. Promoters activated by MerR proteins have
unusually long spacers between two RNA polymerase binding motifs typically
located about 35 and 10 base pairs upstream of their transcription start sites. The
presence of 2-3 additional base pairs results in two structural changes which prevent
RNA polymerase binding: the –35 and –10 elements are too far apart and no longer
on the same side of the DNA double helix. Activated MerR proteins bound to cognate
promoters cause DNA to bend and twist the –35 and –10 elements back into
alignment, allowing  RNA polymerase binding and transcriptional initiation (1).
X-ray crystal structures have been available for three MerR proteins in complex with
cognate promoter DNA: BmrR (PDB IDs 1exj (2), 1r8e (3) and 1exi (2)) and Mta
(1r8d (3)), both of which activate the expression of multidrug efflux pumps in
Bacillus subtilis; and SoxR (2zhg (4)), an oxidative stress sensor in Escherichia coli.
Each of these structures contains promoter DNA that is bent and twisted, and each
complex was shown to be transcriptionally active: BmrR was crystallized with known
inducers bound to the protein; Mta was crystallized as a constitutively active
truncation mutant named MtaN; and SoxR was crystallized in its oxidized, active
state.
TipAL (thiostrepton induced protein A, long form) is a MerR protein from
Streptomyces lividans, a soil-dwelling, saprophytic bacterium. Its C-terminal sensor
domain, TipAS (thiostrepton induced protein A, short form), recognizes various
thiopeptide antibiotics including micrococcin, thiostrepton, nosiheptide, promothiocin
and others (5). After antibiotic binding, TipAL upregulates the expression of its own
gene and several others that have not been characterized (6). tipA messenger RNA
contains two ribosome binding sites and is translated to full-length TipAL as well as
the isolated sensor domain TipAS. Thus TipAL detects thiopeptide antibiotics and
responds by upregulating the production of both TipAL and TipAS. TipAS is
produced in >20-fold excess over TipAL (7) and neutralizes antibiotics by irreversibly
binding to them (figure 1). The tipA gene confers resistance to thiopeptide antibiotics
in vivo: it was shown that disruption of the tipA gene leads to 5-fold increased
sensitivity to thiostrepton in S. lividans (8). It is noteworthy that Streptomyces strains
that produce thiopeptide antibiotics generally lack the tipA gene (9) and instead
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possess tsr, a much more effective resistance gene. tsr encodes a methylase that
modifies the ribosome to prevent binding of thiopeptide antibiotics.
The solution structure of TipAS in the absence of antibiotics has been solved by NMR
spectroscopy (10). The C-terminal ~90 residues of TipAS form a rigid structure
comprising 5 ! helices in an arrangement reminiscent of the globin fold. Residue
C214, which spontaneously forms a covalent bond with many thiopeptide antibiotics,
is located next to a deep hydrophobic cleft. The N-terminal ~50 residues of apo-
TipAS are flexible; they form stable ! helical structure only after antibiotic binding.
The N-terminal, DNA binding domain of TipAL, TipAN (thiostrepton induced
protein A, N terminal domain) is homologous to the DNA-binding domains of all
MerR proteins, including Mta (48% sequence identity), SoxR (26%), BmrR (24%)
and, of course, MerR (28%).
We have undertaken structural studies of TipAN and its interaction with the tipA
promoter (ptipA) as a part of our investigation into TipAL-mediated transcriptional
activation and antibiotic resistance. Here we present the crystal structure of TipAN
bound to the tipA promoter. We find that in contrast to other MerR protein·promoter
structures, DNA is not bent or twisted into a transcriptionally active form.
Comparisons of TipAN·ptipA and MtaN·pmta rationalize why the isolated MtaN
domain is sufficient for transcriptional activation while TipAN is not, and point to a
mechanism for TipAL activation. We present biophysical data indicating that the
TipAN dimer is unstable, and we combine our findings with available information
about the TipAS domain to propose a mechanism for antibiotic-induced
transcriptional activation by TipAL.
Materials and Methods
Expression and purification of TipAN
The tipAN coding sequence was PCR-amplified from plasmid pDS8::tipAL (8).
TipAN was expressed using a modified pET22b(+) vector in  Escherichia coli BL21
(DE3). Cells were grown at 37°C in 8 L Miller LB broth (Difco) containing 100 mg/L
ampicillin, in shaking flasks. Expression was induced at OD600 nm 1.0 by addition of
IPTG to a final concentration of 1 mM, and maintained for 4 h. Cells (18 g) were
disrupted using a French pressure cell (Spectronic Unicam). Insoluble cell debris was
removed by centrifugation.
All purification steps were carried out at 4°C. TipAN was precipitated by adding
ammonium sulfate to 70% saturation (w/v). Supernatant was discarded, and
precipitate was dialyzed against MA buffer (20 mM Tris-HCl, 50 mM NaCl, 5 mM
MgCl2, 1 mM EDTA, pH 8). TipAN solution was loaded on a 75 mL Q-Sepharose
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Fast Flow anion exchange column, and eluted with a 400 mL linear gradient of 50 to
635 mM NaCl in MA buffer. Fractions were pooled based on their absorption at 280
nm and analysis by SDS-PAGE. TipAN eluted at a NaCl concentration of 370 mM.
TipAN solution was further purified on a Superdex 75 prep grade size exclusion
column (Amersham Pharmacia) with bed diameter 26 mm and length 60 cm, in
portions of 5 mL per run to prevent aggregation. Protein was eluted with MA buffer
containing 150 mM NaCl at a flow rate of 1 mL/min. Fractions were pooled based on
their absorption at 280 nm and analysis by SDS-PAGE. TipAN eluted at a retention
volume of 164 mL. Based on UV absorption and assuming an extinction coefficient of
5120 AU/M/cm at 280 nm (11), the TipAN concentration after size exclusion
chromatography was 25 µM, and the total yield was 30 mg. Prior to crystallization,
TipAN was further purified by reversed phase HPLC. TipAN was loaded on a Grace
Vydac Protein C4 column with bed diameter 2.2 cm and bed length 25 cm, in portions
of 5 mL per run. Protein was eluted with a linear gradient from solvent A (H2O
containing 0.1% TFA (v/v)) to solvent B (90% acetonitrile, 10% H2O, 0.085% TFA
(v/v)). TipAN eluted at 49% solvent B. No contaminant peaks were detected. The
TipAN solution was lyophilized and stored at –70°C. Prior to crystallization, TipAN
was redissolved in MA buffer containing 150 mM NaCl, and concentrated to 1.0 mM
(12 mg/mL) using a 2 mL, 10 kDa molecular weight cutoff Centricon centrifugal filter
device (Amicon / Millipore).
Preparation of double-stranded tipA promoter DNA
DNA oligonucleotides of sequence 5´-TTG CAC CTC ACG TCA CGT GAG GAG
CG-3´ and 5´-ACG CTC CTC ACG TGA CGT GAG GTG CA-3´ were purchased
from Microsynth, Balgach, Switzerland, in HPLC-purified form. Each strand was
dissolved in 10 mM sodium cacodylate, pH 6.5, to obtain DNA concentrations of 2
mM. Equal amounts of complementary strands were mixed, heated to 98°C, and
slowly cooled to room temperature. The solution was concentrated to 1.5 mM double
strand by means of a 3 kDa molecular weight cutoff centrifugal filter device (Amicon
/ Millipore). Double strand formation was confirmed by NMR spectra showing
hydrogen-bonded imino hydrogens. Concentration was measured by UV
spectroscopy, assuming an extinction coefficient of 491 AU/mM/cm for the double
strand.
Crystallization
Crystals were grown at room temperature by the sitting drop vapor diffusion method.
The reservoir solution was 600 µL of 15% (w/v) PEG-8000, 0.2 M MgCl2, 0.1 M
Tris-HCl at pH 8.5. The protein-DNA complex was prepared immediately before
crystallization by mixing TipAN and DNA stock solutions and MA buffer containing
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150 mM NaCl to obtain final concentrations of 500 µM (6.0 mg/mL) TipAN and 275
µM double stranded DNA. The crystallization drop contained 4 µL protein-DNA
solution and 6 µL reservoir solution. Crystals appeared after one week and grew for
about two weeks, after which they started to decompose. Crystals grew in clusters and
were flat, typically measuring 0.2 mm in diameter and 10 µm in thickness.
Crystals were transferred to cryoprotectant solution (170 mM Tris-HCl at pH 8.5, 330
mM MgCl2, 25% PEG-8000) and soaked for 1 min before flash freezing in liquid N2.
X-ray diffraction and data processing
Diffraction data were recorded at the European Synchroton Radiation Facility
(ESRF), Grenoble, France, beamline ID14 3; and Swiss Light Source (SLS), Villigen,
Switzerland, beamline PX1. Crystals were kept at 100 K in a stream of cold N2.
Diffraction data were processed with the program MOSFLM (12) and subsequently
scaled with programs of the CCP4 suite (13).
Structure determination
The TipAN·ptipA structure was solved by Molecular Replacement, using the software
Phaser (14). A fragment of the MtaN·DNA structure (1r8d) comprising protein
residues N7-H71 was trimmed to those atoms that are common to MtaN and TipAN,
and used as a first search model. A solution with Rfree 53.0% was found using
diffraction data up to 3 Å resolution. This first solution was held fixed, and a second
search was performed using residues K77-R103 of the dimerization helix, again
trimmed to common atoms, as a model. A solution with a plausible relative
orientation of the two models was found, reducing Rfree to 44.0%. These two
components were fixed, and a five base pair fragment of DNA could be placed in a
third search, further reducing Rfree to 41.4%. All three components were refined as
rigid bodies, and side chains and additional amino acids and base pairs were
successively added. Full atom refinement including restrained B-factor refinement
resulted in a final Rfree of 27.4%. Refinement was carried out with Refmac5 (13).
Biophysical characterization
Mass spectrometry. LC-ESI, Q-TOF detected mass spectra were recorded on different
preparations of TipAN. A mass of 12034.4 Da was found, in excellent agreement with
the predicted mass of 12034.6 Da for TipAN minus residue M1.
Circular dichroism. CD spectra were recorded on 16.4 µM TipAN and 14.6 µM
MtaN (see (3) for production and purification) in 150 mM (K/H)3PO4, 15 mM NaCl,
pH 8.0, at room temperature. Spectra were deconvoluted into contributions from
different secondary structure elements with the program CDNN (15).
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Fluorescence anisotropy. Dissociation constants (KD) of TipAN, TipAL, and TipAL
with bound thiostrepton from a double-stranded, singly 5´-fluoresceinated fragment of
ptipA DNA (5´-fluorescein-GGC TTG CAC CTC ACG TCA CGT GAG GAG GCA
GCG T-3´ / 5´-ACG CTG CCT CCT CAC GTG ACG TGA GGT GCA AGC C-3´;
Oligos Etc., Wilsonville, Oregon, USA) were measured by fluorescence anisotropy,
using a PanVera Beacon Fluorescence Polarization System. Measurements were
performed at 25°C in 1 mL 50 mM Tris-HCl at pH 7.5, 150 mM KCl. The
concentration of double-stranded DNA was 1.5 nM, and the protein concentration was
varied from 0 to 20-25 µM in 20-30 steps.
NMR spectroscopy. Jump-return spin echo 1H 1D spectra (16) were recorded on a
Bruker DRX 800 spectrometer at a sample temperature of 293 K. Amide T2 relaxation
time constants were measured by varying spin echo delays between 200 µs and 5.8
ms. NMR samples contained 100 µM TipAN in MA buffer containing 500 mM NaCl
and 5% (v/v) D2O; the concentrations of TipAN and NaCl were varied in individual
experiments.
Results
Crystallography and model building. The structure of the TipAN-DNA complex was
determined to a resolution of 2.9 Å by Molecular Replacement, using fragments of the
MtaN·DNA complex structure (1r8d (3)) as models. The space group was P21212,
with the asymmetric unit containing one TipAN monomer and one half of the DNA
double strand. This posed a problem since the double-stranded, pseudopalindromic
promoter DNA is not perfectly symmetric. Indeed, disorder was observed for the
bases at positions 1 and 10 / –10. These nucleotides were modeled as Gua, Thy, and
Thy, respectively, and appear as non-complementary in our model even though they
are canonical Watson-Crick base pairs in nature. No base-specific crystal contacts are
observed in our structure, and the crystal packing does not allow for base pairing
between the 5´ overhangs as observed in MtaN·pmta (3). We conclude that the two
possible orientations of the DNA double helix are randomly distributed in the
TipAN·ptipA crystal. Nucleotides –14, –13, –12, 12 and 13, protein residues P72–P76
and A104–S109 and the side chains of residues D24, E32, R33, H35, D71, R77, R82,
Q103 and E106 are not defined by electron density and were excluded from the
model. Selected crystallographic statistics and indicators of model quality are given in
Table 1.
Overall structure of the TipAN·DNA complex. TipAN forms a homodimer and, like
MtaN, has the topology !1-!2-"1-"2-!3-!4-!5 (figure 2). Helices !1 and !2 are a
canonical helix-turn-helix motif that contacts the major groove of the tipA promoter.
Strands "1 and "2 form a small, antiparallel " sheet connected by a loop that contacts
TipAN·DNA structure, page C-7
the minor groove of DNA. TipAN dimerizes by forming an antiparallel coiled coil
with the long helix !5. In stark contrast to previously described MerR protein·DNA
structures, where DNA is bent by 47-65°, the tipA promoter is only bent by 17°
(figures 2, 3). The structure of the DNA-binding subdomain encompassing helices
!1-!5 and the " sheet is very similar in TipAN and MtaN, and so is their position
relative to directly bound DNA nucleotides: the rmsd of C! and P atom positions for
protein residues S/Q4-D70 plus DNA nucleotides Cyt–9/Gua9*-Gua–3/Cyt3* is only
0.61 Å between TipAN·ptipA and MtaN·pmta. Likewise, the coiled coil subdomain is
very similar in the two structures, with an rmsd of C! positions of 0.65 Å for residues
H79-M105 and H79*-M105*. There are two major differences between the two
structures: the central nucleotides of promoter DNA are distorted in MtaN·pmta but
much less so in TipAN·ptipA, and the coiled coil subdomain is translated by 13.3 Å
and rotated by 23° relative to the DNA-binding subdomain and DNA.
Protein-DNA interactions, shown in figures 4a and 4b, are very similar in
TipAN·ptipA and MtaN·pmta. Base-specific contacts occur primarily between the
major groove of DNA around nucleotide Gua4 and the recognition helix !2 of the
helix-turn-helix motif. Residue H38 may connect to the minor groove of DNA around
nucleotide Cyt–10 indirectly, via bound H2O, as in MtaN·DNA; this cannot be shown
conclusively as the resolution of our structure is insufficient to observe water
molecules. Ten hydrogen bonds are formed between the DNA phosphate backbone
and the protein backbone or side chains.
Interactions between coiled coil and DNA-binding subdomains. The most striking
structural differences between activated MtaN·pmta and inactivated TipAN·ptipA are
found in the interface between the DNA-binding subdomain and the coiled-coil
dimerization helix (see Discussion). This interface is shown in figure 3c. Interactions
occur primarily between !3 and the dimerization helix !5 of the same protein chain
and to a lesser extent between !3 and !5* of the adjacent monomer. In addition to
many hydrophobic interactions, residues Y55 and Q51 on !3 form hydrogen bonds to
Q83, R82 and H79 on !5*.
Sequence alignments. An alignment of the TipAL sequence with N-terminal domains
of Mta and BmrR is shown in figure 5. In MtaN, the coiled coil dimerization domain
is stabilized by inter-chain salt bridges between K84 and D102, and between K91 and
D95 (3). These residues correspond to H84, E102, I91, and N95 in TipAN, which are
unlikely to form salt bridges, although this could be partially compensated by
hydrophobic contact between I95 and L94. In ptipA, 14 out of 23 base pairs are the
same as in pmta, and ptipA is almost perfectly centro-symmetric (figure 2). It is
noteworthy that the central base pair in ptipA is Gua-Cyt, whereas it is Ade-Thy in
other MerR promoters. In the transcriptionally active MtaN·DNA and
BmrR·TPP+·DNA complexes, this base pair is broken as a consequence of protein
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binding and DNA bending; however, it was shown that mutating this base pair to
Ade-Thy did not significantly enhance protein binding, even though Gua-Cyt base
pairing is stronger than Ade-Thy (3).
DNA binding affinities. Fluorescence affinity measurements revealed that the
dissociation constants (KD) from ptipA were 25 ±6 µM for TipAN, 23 ±9 µM for apo-
TipAL and 5.4 ±1.3 µM for TipAL with bound thiostrepton (data not shown). Thus
the binding affinity of TipAN is the same as that of apo-TipAL; it increases slightly
after antibiotic binding to TipAL. The observed dissociation constants are three orders
of magnitude higher than those measured for MtaN binding to pmta or BmrR binding
to pbmr under the same conditions (3).
Dynamic instability of the TipAN dimer. Several observations indicate that TipAN in
the absence of DNA forms unstable dimers at micromolar concentrations. First, in the
process of TipAN purification, we noted that the protein elutes as an asymmetric peak
that shifted towards lower molecular weights when lower concentrations of protein
were loaded on the column (data not shown), indicating that TipAN oligomerizes at
concentrations in the low µM range. Second, 
1
H-
15
N HSQC NMR spectra of TipAN
were of very poor quality and contained only weak signals (data not shown),
consistent with intermediate exchange on the chemical shift time scale. Assuming a
diffusion-controlled association rate (about 10
8
 M
–1
s
–1
), a KD of oligomerization in the
low µM range would correspond to a dissociation rate in the low (ms)
–1
 range, which
would lead to broad, weak NMR signals as observed. Amide 
1
H T2 relaxation time
constants, which depend on molecular tumbling rates and thus on molecular mass,
increased at low concentrations of protein and high concentrations of NaCl (figure 7);
both of these conditions are expected to disfavor dimerization or aggregation of
TipAN. Finally, our fluorescence anisotropy measurements showed that TipAN has a
much lower affinity for cognate DNA than MtaN (see above). TipAN binds to DNA
as a dimer; the free energy of binding is effectively doubled if a preformed protein
dimer binds to DNA with two binding sites simultaneously instead of two protein
monomers binding independently, and a low stability of the TipAN dimer thus leads
to a low DNA binding affinity. It is conceivable that the affinity of TipAN for ptipA
would drastically increase if residues H84, E103, I91, and N95 were mutated such
that salt bridges as observed in MtaN could be formed, stabilizing the dimer.
CD spectra of TipAN and MtaN (data not shown) showed a significantly lower
content of canonical secondary structure for TipAN (38% ! helix) than for MtaN
(48% ! helix). The crystal structure of MtaN in the absence of DNA (1jbg (17))
contains 67% helix.
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Discussion
In complex with TipAN, tipA promoter DNA is only bent by 17° (figure 3), in stark
contrast to a bending angle of 47° in MtaN·pmta, ~50° in BmrR·TPP
+
·pbmr, and 65°
in SoxR·psoxS. Since DNA distortion is a prerequisite for transcription from MerR-
like promoters, this finding implies that the isolated TipAN domain is insufficient for
transcriptional activation. This comes as a surprise given that highly homologous
MtaN strongly activates mta transcription in the absence of its regulator domain.
Comparison of the TipAN·ptipA and MtaN·pmta complex structures shows that DNA
is bound in the same way in both structures, i.e. the orientation of helices !1-!4 and
the " sheet (the DNA-binding subdomain) relative to bound DNA is identical in the
two complexes (figures 3, 4b). Differences are found in the central region of DNA
and in the orientation of the (!5)2 coiled coil relative to the DNA-binding subdomain
(figures 3, 4c). Thus, the switch between inactive and activated MerR protein-DNA
complexes lies in this subdomain interface. The most striking difference between the
subdomain interfaces is at residue Y55 in helix !3 in TipAN, which forms hydrogen
bonds with H79, R82 and Q83 of helix !5, stabilizing the inactive conformation. The
corresponding residue in MtaN is F55, which cannot form hydrogen bonds (figure
4c). This explains why the default conformation of TipAN is inactive, and an
activated receptor domain is required for transcription; whereas MtaN is active in the
absence of a receiver domain, and the receiver domain in its inactive state is required
for MtaN to assume its inactivated conformation.
The affinity of both TipAN and TipAL for cognate DNA is very weak, with
dissociation constants of 5-25 µM; the binding of MtaN to pmta or of BmrR to pbmr
is three orders of magnitude stronger under the same conditions (3). The dissociation
constants measured for TipAN and TipAL are higher than the minimum inhibitory
concentration of thiostrepton, which was reported as 0.1-0.6 µM (8). This is no
impediment to the proposed mechanism of antibiotic resistance, however, since the
covalent, irreversible binding of antibiotics to TipAL allows for intracellular
TipAL·antibiotic concentrations exceeding the extracellular antibiotic concentration.
The weak binding of TipA proteins to DNA is related to the instability of the TipAN
dimer, which was observed by CD spectroscopy, size exclusion chromatography and
NMR spectroscopy: the monomerization of TipAN abolishes the cooperative binding
of TipAN molecules to DNA and thus effectively reduces the binding affinity.
We have previously reported that the N-terminal part of the receptor domain TipAS is
flexible in the absence of antibiotic, and forms !-helical structure after ligand binding
(10). Combining this finding with our observation that the switch between inactive
and activated MerR protein·DNA complexes lies in the interface between the DNA-
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binding and coiled-coil subdomains of TipAN, we propose the following model of
antibiotic-induced transcriptional activation by TipAL (figure 8): In the absence of
antibiotic, TipAN is bound to relaxed, transcriptionally inactive DNA. The structured
part of the TipAS receiver domain is connected to the TipAN coiled coil via the
flexible N-terminal part of TipAS. After antibiotic binding, the N-terminal part of the
TipAS domain forms !-helical structure, pulling TipAS closer to TipAN. The TipAS
domain presses on the DNA-binding subdomain of TipAN, causing TipAN to switch
to its active conformation. As a consequence, bound DNA is distorted in the way
observed in the MtaN·DNA and BmrR·DNA structures, and transcription is initiated.
Our data are insufficient to determine where TipAS contacts the DNA-binding part of
TipAN; however, it is plausible that three consecutive glutamate residues (E132-
E134) in the N-terminal part of TipAS form salt bridges to a positively charged region
on the surface of TipAN such as residues R90, K93, and K96 on helix !5. The
proposed structure of the activated TipAL·DNA complex is similar to the activated
BmrR·DNA structure, where the ligand-binding domain is in contact with the DNA-
binding subdomain as well as the coiled coil domain, in a region that rougly
corresponds to residues 90-96 of TipAN.
In conclusion, we have determined the first structure of a transcriptionally inactive
complex of MerR·protein with cognate promoter DNA. We have shown that the
switch between the active and inactive states lies in the interface between the DNA-
binding and coiled-coil subdomains, and we have presented a possible mechanism of
antibiotic-induced transcriptional activation by TipAL.
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Figures and Tables
Table 1: Crystallographic statistics.
Beamline SLS PX1
Wavelength 0.9001 Å
Space group P21212
Unit cell parameters a = 45.9 Å, b = 67.5 Å, c = 73.1 Å
Matthews volume 2.83 Å3/Da
(overall) (outer shell)
Resolution limits 30.0 – 2.90 Å 3.06 – 2.90 Å
Rmerge 0.057 0.298
Total number of observations 22839 3338
Unique observations 5160 774
Multiplicity 4.4 4.5
Mean(I) / stdev(I) 18.1 5.0
Completeness 97.5% 98.0%
Resolution limits 30.0. – 2.9 Å
R factor 23.9%
Free R factora 27.4%
Average B factor for protein 56 Å2
Average B factor for DNA 59 Å2
Number of protein atoms in model 755
Number of DNA atoms in model 428
Rms deviation from ideal bond lengths 0.008 Å
Rms deviation from ideal bond angles 1.3°
Ramachandran statistics:b
Residues in most favored regions 95.4%
Residues in additional allowed regions 4.6%
                                                 
a Rfree was calculated for a randomly chosen set of 4.5% (245) of reflections, which were excluded from
any refinement.
b Considering 87 non-Gly, non-Pro protein residues in model; determined using PROCHECK
(Laskowski et al. 1993).
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Figure 1: Cartoon of the TipA antibiotic resistance mechanism. See text for
details.
Figure 2: Overview of the TipAN·ptipA structure. Residues P72-P76, which
were not included in the model, are represented by gray loops.
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Figure 3: Comparison of the TipAN·pt ipA  (left) and MtaN·pmta (right)
structures. (a) Overall structures and DNA bending. While the DNA-binding part
with DNA nucleotides directly bound to it (highlighted in yellow) as well as the
coiled coil (purple) are virtually identical in both structures, their position
relative to each differs drastically: in TipAN·ptipA, the coiled coil is in closer
contact with the DNA-binding part (blue), and DNA (green) is bent by 17°
around the central base pair, rather than 47° as in MtaN·pmta. (b) Protein-DNA
contacts are virtually identical in both complexes. (c) Contacts between the
coiled coil and the DNA-binding part are markedly different in the two
complexes. In TipAN·ptipA, hydrogen bonds are observed from Y55 to H79 and
R82 and between Q83 and Q51, while interactions between the coiled coil and
the DNA-binding part of MtaN are exclusively hydrophobic. Hydrogen bonds
are shown as cyan lines.
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Figure 4: Schematic diagram of TipAN-DNA contacts (left) and MtaN-DNA
contacts (right). Only one half-site is shown for each promoter, and the twofold
pseudosymmetry axis marked is with an orange dot. Hydrogen bonds involving
protein side chains are shown as blue lines; hydrogen bonds involving the
protein backbone are shown as green lines; and van der Waals contacts are
shown as yellow lines. Contacts that are only observed for one monomer of the
MtaN dimer are shown as dashed lines. ptipA nucleotides that were not included
in the model are shown in gray.
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Figure 5: Sequence alignment of TipAL and Mta. Secondary structure (indicated
above the sequences) was taken from the crystal structures of TipAN and 1R8D
(3), and from Kahmann & al. (10). Amino acid residues in direct contact with
DNA are highlighted in pale yellow for van der Waals contacts to DNA
backbone; dark yellow for van der Waals contacts to bases; pale green for H-
bonds to DNA backbone; and dark green for base-specific H-bonds. Colored
bars above the sequences indicate functional units as in Fig. 8. The figure was
prepared with MultAlin (18) and ESPript (19).
Figure 6: Promoters of tipA and mta. The –35 and –10 promoter elements
recognized by RNA polymerase, and the spacing between them are indicated
above the sequences. Nucleotides in direct contact with protein are highlighted in
pale yellow for van der Waals contacts to DNA backbone; dark yellow for van
der Waals contacts to bases; pale green for H-bonds to DNA backbone; and dark
green for base-specific H-bonds. Orange dots indicate twofold pseudosymmetry
axes; bases that conform to this symmetry are in boldface. Bases that are
conserved in both promoters are highlighted in red. Boxes indicate the fragments
that were used for TipAN·ptipA and MtaN·pmta structure determination; the 5´
Thy of the (–) strand was artificially changed to Ade in both cases. Residue
numbers are as in crystal structures, and PDB chain identifiers are indicated to
the left of the sequences.
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Figure 7: NMR spectroscopic analysis of TipAN in the absence of DNA,
providing evidence for aggregation. (a) Amide/aromatic region of 1D 
1
H spectra
at 500 mM NaCl and 38 µM (top) or 595 µM TipAN (bottom). Acquisition times
were 22 and 1.5 min. (b) Dependence of amide 
1
H T2 relaxation time constants
on TipAN concentration, at a NaCl concentration of 500 mM. (c) Dependence of
amide 
1
H T2 relaxation time constants on NaCl concentration, at a TipAN
concentration of 100 µM.
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Figure 8: Models of MerR promoters in their activated and inactivated form.
–35 and –10 promoter elements are highlighted in magenta (+ strand) and cyan
(– strand). (a) Canonical !
70
 promoter in an undistorted B-DNA conformation.
–35 and –10 elements are separated by 17 base pairs, and the promoter is
constitutively active. (b) Extrapolated mta promoter activated by MtaN. –35 and
–10 elements are separated by 19 base pairs, but DNA is distorted in such a way
that they are recognized by RNA polymerase. (c) Extrapolated tipA promoter
with bound TipAN. –35 and –10 elements are separated by 19 base pairs. The
slight bend in the DNA around the central base pair is overcompensated by
bends in the opposite direction around bases XX, effectively withdrawing –35
and –10 elements from RNA polymerase. (d) MerR family promoter in an
undistorted B-DNA conformation. –35 and –10 elements are separated by 19
base pairs, and not recognized by RNA polymerase because they are too far apart
and twisted away from each other by 72°.
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Figure 9: Cartoon of thiostrepton-induced, TipAL-mediated transcriptional
activation. Upon binding of antibiotic (CPK-colored spheres) to the structured
part of TipAS (orange), the previously flexible N-terminal part of TipAS (red)
forms additional !-helical structure (10). This brings TipAS closer to TipAN
(blue/purple), pushing the DNA-binding subdomains (blue) together.
Consequently, bound promoter DNA is bent and twisted, which brings –10 and
–35 promoter elements into alignment, allowing RNA polymerase to bind and
initiate transcription. Figures 2, 3 and 8 were prepared with MacPyMol (20).
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Bacteria are able to switch between two mutually exclusive life-
styles, motile single cells and sedentary multicellular communities
that colonize surfaces. These behavioral changes contribute to an
increased fitness in structured environments and are controlled by
the ubiquitous bacterial second messenger cyclic diguanosine
monophosphate (c-di-GMP). In response to changing environ-
ments, fluctuating levels of c-di-GMP inversely regulate cell motil-
ity and cell surface adhesins. Although the synthesis and break-
down of c-di-GMP has been studied in detail, little is known about
the downstream effector mechanisms. Using affinity chromatog-
raphy, we have isolated several c-di-GMP-binding proteins from
Caulobacter crescentus. One of these proteins, DgrA, is a PilZ
homolog involved in mediating c-di-GMP-dependent control of C.
crescentus cell motility. Biochemical and structural analysis of DgrA
and homologs from C. crescentus, Salmonella typhimurium, and
Pseudomonas aeruginosa demonstrated that this protein family
represents a class of specific diguanylate receptors and suggested
a general mechanism for c-di-GMP binding and signal transduction.
Increased concentrations of c-di-GMP or DgrA blockedmotility in C.
crescentus by interfering with motor function rather than flagellar
assembly. We present preliminary evidence implicating the flagel-
lar motor protein FliL in DgrA-dependent cell motility control.
diguanylate receptor ! motility ! PilZ ! c-di-GMP ! second messenger
Cyclic purine nucleotides are ubiquitous second messengersinvolved in cell signaling. They are produced through the
action of growth factors, hormones, or neurotransmitters and
elicit their response by acting on a range of downstream effector
proteins such as protein kinases, transcription regulators, gated
ion channels, or GTPase nucleotide exchange factors. Although
cAMP is widespread through all kingdoms of life, cGMP seems
to be restricted to signaling in eukaryotes. Recently, a third
major cyclic nucleotide messenger, cyclic diguanosine mono-
phosphate (c-di-GMP) has emerged as a ubiquitous signaling
molecule in prokaryotes, where it antagonistically controls mo-
tility and virulence of planktonic cells on one hand and cell
adhesion and persistence of multicellular communities on the
other (1, 2) [supporting information (SI) Fig. 7]. C-di-GMP is
synthesized from two molecules of GTP and degraded into the
linear dinucleotide pGpG by the opposing activities of diguany-
late cyclases (DGC) and c-di-GMP-specific phosphodiesterases
(PDE). DGC and PDE activities are comprised in GGDEF and
EAL domains, respectively (3–8), which represent two large
families of output domains found in bacterial one- and two-
component signal transduction systems (9, 10).
The molecular principles of c-di-GMP signaling have been
studied in the model organism Caulobacter crescentus, where
c-di-GMP coordinates the developmental transition from a
motile swarmer cell to a surface-attached, replication-competent
stalked cell. Both acquisition of flagellar motility in the predi-
visional cell and its replacement by an adhesive organelle later
in development are controlled by c-di-GMP. TipF, an EAL
domain protein, is required for an early step of flagellum
assembly in the predivisional cell (11), whereas the diguanylate
cyclase PleD is involved in flagellum ejection and subsequent
steps in pole remodeling (3, 12–15). Similarly, the second
messenger c-di-GMP regulates motility, adhesion factors, and
biofilm formation in a wide variety of bacterial pathogens
including Yersinia, Pseudomonas, Vibrio, and Salmonella (1, 2).
C-di-GMP influences flagellar motility as a function of growth
(16) or adaptation to surfaces (17), affects pilus assembly (18),
and controls the production of surface structures such as fim-
briae and exopolysaccaride matrices (19). The wide variety of
cellular functions that are affected by c-di-GMP calls for multiple
receptors and signaling mechanisms. However, little information
is available on specific targets of c-di-GMP action. With the
exception of a component of the cellulose synthase complex from
Gluconacetobacter (20, 21) and the recent prediction of a can-
didate c-di-GMP-binding domain (22, 23), no c-di-GMP effector
proteins have been reported. We have designed a biochemical
approach to purify and characterize c-di-GMP effector mole-
cules from C. crescentus crude cell extracts.
Results
Purification of c-di-GMP-Binding Proteins from C. crescentus. Based
on the assumption that c-di-GMP signal transduction depends on
specific receptor proteins, we designed a biochemical purifica-
tion strategy to identify such components. C-di-GMP-binding
proteins from C. crescentus were purified by two consecutive
chromatography steps with Blue Sepharose CL-6B and affinity
chromatography with GTP immobilized on epoxy-activated
Sepharose 4B (Amersham Pharmacia, Piscataway, NJ). UV
cross-linking with c-[33P]di-GMP was used to identify proteins
with specific binding activity for c-di-GMP (see Materials and
Methods and SI Table 2). Two binding proteins with apparent
molecular masses of 47 and 36 kDa were detected in the 0.4–0.7
M NaCl eluate of the Blue Sepharose column (Fig. 1 A and B,
lane 3), and the 0.7–0.9 M NaCl fraction contained several small
c-di-GMP-binding proteins with apparent molecular masses of
8–12 kDa (Fig. 1 A and B, lanes 4 and 5). The latter fraction was
dialyzed, concentrated, and separated on a GTP-epoxy-
Sepharose 4B affinity column (Fig. 1 A and B, lane 4). One of
these proteins (labeled c in Fig. 1B) was identified by tandem
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mass spectrometry (MS/MS) as the product of gene CC1599, a
conserved hypothetical 12.5-kDa protein that we consequently
renamed as diguanylate receptor A (DgrA). Sequence compar-
ison disclosed DgrA as a member of the PilZ protein family,
members of which have recently been proposed by bioinformat-
ics to be c-di-GMP effector proteins (22).
DgrA Is a Diguanylate Receptor Protein. To confirm that the
identified protein is a c-di-GMP receptor, dgrA, was subcloned
into the expression vector pET-42b, and the recombinant His6-
tagged protein was purified by nickel–nitrilotriacetic acid affin-
ity chromatography. Like the semipurified protein from C.
crescentus (Fig. 1B), the recombinant protein showed strong
labeling upon UV cross-linking with c-[33P]di-GMP (Fig. 2A),
confirming that DgrA is a c-di-GMP receptor protein. UV
cross-linking experiments with DgrA in the presence of 60 nM
33P-labeled c-di-GMP and increasing concentrations of cold
c-di-GMP, GTP (200 !M), or pGpG (200 !M) indicated that
DgrA binds c-di-GMPwith high affinity and specificity (Fig. 2B).
C-di-GMP binds to DgrA in a noncovalent manner because no
radiolabeled c-di-GMP was incorporated without UV irradia-
tion (Fig. 2B). The dissociation constant for c-di-GMP of the
recombinant DgrA was determined by using the UV cross-
linking assay (Table 1). Saturated incorporation of radiolabeled
c-di-GMP was already observed at 50 nM, indicating that the Kd
of DgrA for c-di-GMP is !50 nM.
To test whether other members of the PilZ protein family also
bind c-di-GMP, we analyzed several ortho- or paralogs of DgrA,
including CC3165 (renamed as DgrB), YcgR from Salmonella
typhimurium (24), and PA4608 from Pseudomonas aeruginosa
(see Fig. 6). As shown in Fig. 2A, all four proteins were efficiently
labeled with c-[33P]di-GMP upon UV cross-linking, whereas the
control protein BSA did not incorporate c-di-GMP. The c-di-
GMP-binding constants of DgrB, YcgR, and PA4608 were
determined by performing UV cross-linking experiments with
50 nM receptor protein in the presence of increasing concen-
trations of 33P-labeled c-di-GMP (50–1,000 nM). All wild-type
diguanylate receptor proteins exhibit a binding affinity in the
nanomolar range (Table 1). Taken together, these data demon-
strate that DgrA and its homologs containing a PilZ domain are
members of a class of small diguanylate receptor proteins, which
bind c-di-GMP, but not other guanine nucleotides, with high
1 2 3 4 5
c
d
a
b
A
B
Fig. 1. Isolation of c-di-GMP-binding proteins from C. crescentus. (A) Coo-
massie blue-stained SDS/polyacrylamidegelwithprotein fractions used forUV
cross-linkingwith c-[33P]di-GMP. Lane 1, 100.000"g supernatant; lane 2, 60%
ammonium sulfate precipitation; lane 3, 0.4–0.7 M NaCl eluate from Blue
Sepharose; lane 4, 0.7–0.9MNaCl eluate fromBlue Sepharose; and lane 5, 125
mM NaCl eluate from GTP-Sepharose column. (B) Autoradiograph of SDS/
polyacrylamide gel shown in A. C-di-GMP-binding proteins a, b, and d were
identified by MS/MS. Protein c was identified by MS/MS as hypothetical
protein CC1599 and was renamed DgrA.
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Fig. 2. DgrA is a member of a new family of c-di-GMP-binding proteins. (A)
UV cross-linking of purified His6-tagged diguanylate receptor proteins with
c-[33P]di-GMP. The following proteins were used: DgrA (CC1599; C. crescen-
tus), DgrB (CC3165; C. crescentus), PA4608 (P. aeruginosa), YcgR (S. typhi-
murium), and BSA (control). The Coomassie blue-stained gel (Left) and the
autoradiograph (Right) are shown. (B) UV cross-linking of 10 !MDgrA in the
presence of 60 nM 33P-labeled c-di-GMP. Autoradiograph (Upper) and
Coomassie-stained gel (Lower). (Left) Samples were supplemented with in-
creasing concentrations of nonlabeled nucleotides as indicated. (Right) Con-
trols were carried out in the absence of UV irradiation or with BSA.
Table 1. Binding constants of diguanylate receptor proteins
determined by UV cross-linking with c-#33P$di-GMP
Organism Protein Kd, nM %Kd*
C. crescentus DgrB 132 36
DgrA
WT !50 14
R11AR12A ND —
D38A 761 149
W75A 6,200 496
S. typhimurium YcgR 182 29
P. aeruginosa PA4608 !50 27
The protein concentration used for binding assay was 50 nM. ND, not
detectable.
*S.E.
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affinity. Thus, these proteins represent bona fide diguanylate
receptor proteins and may be involved in the response of specific
cell functions to fluctuating concentrations of c-di-GMP (2).
DgrA and DgrB Mediate c-di-GMP-Dependent Motility Control in C.
crescentus. Low concentrations of c-di-GMP are generally asso-
ciated with flagella- or pili-based motility of single planktonic
cells, whereas increased concentrations of c-di-GMP promote
multicellular traits and efficiently block cell motility (2). In
agreement with this finding, C. crescentus cells are nonmotile in
the presence of a plasmid-borne copy of dgcA, which encodes a
highly active, soluble diguanylate cyclase (15) (Fig. 3A). Electron
micrographs and immunoblot experiments showed that these
cells were flagellated and expressed normal levels of f lagellins
(data not shown), arguing that increased c-di-GMP concentra-
tions interfere with flagellar function rather than with the
expression or assembly of flagellar components. To test whether
motility control by c-di-GMP involves dgrA or dgrB, single and
double in-frame deletion mutants were generated by using a
two-step homologous recombination procedure (see SI Materials
and Methods). In contrast to C. crescentus wild-type, %dgrA and
%dgrB mutants were motile even in the presence of the dgcA
plasmid (Fig. 3A). Motility was not the result of a reduction of
the c-di-GMP concentration because cellular levels of c-di-GMP
in these mutants were indistinguishably high (data not shown).
At low cellular concentrations of c-di-GMP, motility phenotypes
were not significantly altered in the deletion mutants (data not
shown), indicating that DgrA and DgrB affect cell motility
primarily at conditions where the level of c-di-GMP is elevated.
Together, these data suggested that the c-di-GMP-binding pro-
teins DgrA and DgrB are part of a signal transduction pathway
that interferes with flagellar function in response to high con-
centrations of c-di-GMP. In agreement with this suggestion,
overexpression of dgrA or dgrB from a plasmid efficiently
blocked motility on swarmer plates (Fig. 3B) and in liquid media
as observed microscopically (data not shown).
Analysis of c-di-GMP Binding to the Diguanylate Receptor by NMR
Spectroscopy. The available NMR structure and resonance as-
signments of the DgrA homolog PA4608 from P. aeruginosa (25)
[Protein Data Bank (PDB) ID code 1YWU; Biological Magnetic
Resonance Bank (BMRB) ID code 6514]‡ provided an oppor-
tunity to characterize the ligand-binding site on a molecular level
and to investigate the structural consequences of ligand binding.
PA4608 carrying an N-terminal His6 tag was produced in
uniformly 15N- and 13C-labeled form for NMR spectroscopy.
The 1H and 15N chemical shifts observed for pure PA4608 were
in good agreement with those reported in BMRB entry 6514.
When c-di-GMP was added to the protein, 1H-15N heteronuclear
sequential quantum correlation spectra (HSQC) changed dra-
matically (SI Fig. 8). Free and ligand-bound PA4608 were in slow
exchange on the NMR chemical shift time scale, and titration
curves were in agreement with a KD in the sub-!M range (data
not shown). To assign resonances of the PA4608*c-di-GMP
complex, exchange (EXSY) spectra were recorded on a roughly
3:1 mixture of free and c-di-GMP-bound PA4608 at 313 K.
Standard triple-resonance NMR spectra recorded on PA4608
saturated with c-di-GMP were used to complete the backbone
resonance assignments. No resonances were observed for resi-
dues Met3–His12 (His6 tag), His22, Phe33–Ile36, Gly73, Ile91,
Glu125, Leu128, and Asp130–Leu138. These residues are probably
flexible on a microsecond to millisecond time scale, and peaks
are broadened beyond detection because of intermediate chem-
ical exchange. Secondary 13C" and 13C# shifts (26) showed that
the secondary structure of PA4608 remained essentially un-
changed after ligand binding (SI Fig. 9).
To localize the ligand-binding site on the protein surface,
backbone amide 1H and 15N chemical shifts of the PA4608*c-
di-GMP complex were compared with those of the free protein,
and the differences were mapped on the structure of the free
protein (see Fig. 5 and SI Fig. 8). Large shift differences were
found on one face of the #-barrel (around Val58, Ile63), in the C
terminus (Val142, Ala144), and in the N terminus (Arg30–Asp39).
We conclude that c-di-GMP binds to the outside of the #-barrel
close to Val58 and that the termini, which are partially f lexible
in the apo form, fold around the bound ligand. Presumably the
side chain N-H group of Trp99 forms a hydrogen bond with the
ligand because the 15N$1 and 1H$1 resonances strongly shift
toward higher chemical shifts by 8.24 and 1.66 ppm, respectively.
Because of their distinct chemical shifts (&10.7 ppm), the H1
imino hydrogens of guanine in c-di-GMP could be identified
once the assignment of protein backbone 1HN and tryptophan
1H$1 resonances had been completed. Because four separate H1
resonances of about equal intensity are observed for c-di-GMP
in complex with PA4608 and each molecule of c-di-GMP con-
tains two guanine bases, c-di-GMP binds to PA4608 as a dimer.
Consistent with the ligand-binding site outlined above, two of
these H1 imino resonances show intermolecular NOEs to Leu64
and Trp99 (SI Fig. 10).
‡Residue numbering for PA4608 as in Biological Magnetic Resonance Bank ID code 6514,
which differs from that in Protein Data Bank structure 1YWU by'22, is used throughout
this work.
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Fig. 3. DgrA and DgrB are involved in motility control by c-di-GMP. Motility
behavior of C. crescentus wild-type strain CB15 and mutants is shown on
semisolid agar plates. Three different colonies from independent conjugation
experiments are shown. (A) The following strains containing plasmid
pUJ142::dgcA or control plasmid pUJ142 were analyzed: CB15/pUJ142::dgcA
(a), CB15%dgrA/pUJ142::dgcA (b), CB15dgrAW75A/pUJ142::dgcA (c),
CB15%dgrB/pUJ142::dgcA (d), CB15%dgrA%dgrB/pUJ142::dgcA (e), and CB15/
pUJ142 (f). (B) Overexpression of dgrA or dgrB from the lactose promoter
(Plac) repressed C. crescentus motility. (a) CB15/pBBR (vector control). (b)
CB15/pBBR::dgrA. (c) CB15/pBBR::dgrB. (C) Levels of class II, class III, and class
IV structural components of the C. crescentus flagellum were determined by
immunoblot analysis for the following strains: CB15/pBBR (wild-type),
CB15/pBBR::dgrA (DgrA), CB15/pBBR::dgrB (DgrB), and the extragenic digua-
nylate receptor motility suppressors CB15dms0541 pBBR::dgrA (dms0541).
The motility behavior of each strain is shown on top of the graph.
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Amide 15N T1 and T2 relaxation times and heteronuclear
{1H}-15N NOEs were measured at 293 K for free and c-di-GMP-
bound PA4608 (data not shown). Isotropic rotational correlation
times (%c) were determined from these data with the program
TENSOR (27) as 11.3 and 12.3 ns for free and ligand-bound
protein, respectively. These %c are in reasonable agreement with
values expected for monomeric apo-PA4608 (16.7 kDa, 9.8 ns)
and c-di-GMP-bound PA4608 (18.1 kDa, 10.6 ns). Thus, PA4608
is a monomer before and after ligand binding.
C-di-GMP-Binding Mutants of DgrA Are Unable to Control Motility.
Alignments of the amino acid sequences of PA4608, DgrA,
DgrB, and YcgR revealed that the key residues that were
postulated based on NMR data to be involved in c-di-GMP
binding to PA4608 are conserved among other diguanylate
receptor proteins (see Fig. 6). To probe the c-di-GMP-binding
site of DgrA and to define the minimal requirements for
c-di-GMP binding, residues Arg11, Arg12, Asp38, and Trp75 were
replaced with Ala, and the mutant proteins were analyzed for
c-di-GMP binding. Mutants R11A/R12A and W75A strongly
reduce c-di-GMP binding, whereas mutant D38A is still able to
bind c-di-GMP (see Fig. 5A). In agreement with this result, the
binding constant for the D38A mutant was marginally increased
to 740 nM, whereas the Kd for the W75A mutant (6.4 !M) was
increased 100- to 1,000-fold compared with wild type (Table 1).
Binding of c-di-GMP was completely abolished in the R11A/
R12A mutant. To analyze the importance of c-di-GMP binding
for DgrA-mediated signaling, the dgrA mutant alleles were
tested for functionality in vivo. As indicated above, overexpres-
sion of wild-type dgrA renders cells nonmotile (Fig. 4B; see also
Fig. 6B). In contrast, overexpression of dgrAD38A,
dgrAR11AR12A, or dgrAW75A only partially affected motility
(Fig. 5B). In particular, changing Trp75 to Ala almost completely
abolished the ability of DgrA to block motility under these
conditions (Fig. 5B). Also, when the dgrAW75A mutant allele
was expressed in single copy from its original chromosomal
locus, cells were fully motile even in the presence of the dgcA
plasmid, arguing that DgrAW75A can no longer control motility
in response to increased c-di-GMP levels (Fig. 3). We isolated
suppressors that alleviated the dgrA-mediatedmotility block (see
Materials and Methods). One of the intragenic dms (diguanylate
receptor motility suppressors) mutations mapped to Val74, in the
immediate vicinity of the Trp residue critical for c-di-GMP
binding (Figs. 5B and 6). Other intragenic dmsmutations (Asp62,
Gly82) mapped to conserved residues of DgrA, emphasizing the
functional importance of these residues (Fig. 6). In conclusion,
these results support the view that ligand binding is essential for
the regulatory function of the diguanylate receptor and suggest
that DgrA blocks motility in its c-di-GMP-bound state.
Motility Control by DgrA Correlates with Cellular Levels of the FliL
Motor Protein. Immunoblot analysis revealed that overexpression
of dgrA or dgrB blocks motility without interfering with the
expression of known class II, class III, or class IV components
of the flagellar hierarchy (Fig. 3C). Because the expression of
each class of genes depends on the successful expression and
assembly of components of the preceding class of the hierarchy
(28), this result suggested that flagella are assembled normally
in cells overexpressing dgrA or dgrB. In agreement with this
suggestion, f lagella were readily observed by electron micros-
copy in these nonmotile cells (data not shown). The only flagellar
protein whose concentration was severely affected in cells over-
expressing dgrA was FliL (Fig. 3C). The C. crescentus fliL gene
is not part of the flagellar hierarchy, and its product is not
assembled into the flagellar structure (29). However, fliL is
required for flagellar rotation (29). To examine whether reduced
FliL levels are linked to motility, we screened the pool of dms
mutants (see above) for extragenic suppressors (see Materials
and Methods). From a total of 120 independently isolated motile
suppressors, only one mapped to the chromosome. This sup-
pressor mutation (dms0541), which mapped to gene CC3587
coding for the ribosomal protein S1, not only restored motility
but also reestablished normal levels of FliL (Fig. 3C).
Discussion
Motility control by c-di-GMP is implemented through gene
expression, organelle assembly, or motor function (2). In C.
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Fig. 4. Combined amide 1H and 15N shift differences (%&) between PA4608
in its free and ligand-bound form. Shift differences are color-coded on the
structure of free PA4608 (PDB 1YWU, model 12). Combined chemical shift
differences were calculated as %& ( )([(%&H)2 ' (%&N/5)2]/2). These data are
also shown in SI Fig. 8. Residue Trp99 is shown as sticks, and N$1 and H$1 are
shown in red to highlight the large %& value (1.67 ppm) for these atoms.
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Fig. 5. C-di-GMP binding and motility control of DgrA mutants. (A) UV
cross-linking of different DgrA mutant proteins with c-[33P]di-GMP. Coomas-
sie blue-stained SDS/PAGE (Upper) and autoradiograph (Lower) with purified
wild-type andmutant DgrA proteins (10 !M) are shown. (B) Motility behavior
of C. crescentus wild-type CB15 overexpressing different dgrA alleles:
CB15/pBBR::dgrA (a), CB15/pBBR::dgrAR11AR12A (b), CB15/pBBR::dgrAD38A
(c), CB15/pBBR::dgrAV74A (d), CB15/pBBR::dgrAR11AR12AV74A (e),
CB15/pBBR::dgrAW75A (f), and CB15/pBBR (vector control) (g). Three differ-
ent colonies from independent conjugation experiments are shown.
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crescentus, increased cellular concentrations of c-di-GMP block
motility by interfering with motor function rather than by
altering expression or assembly of structural components of the
flagellum (13). How are increased levels of c-di-GMP sensed and
how is this information transmitted to the flagellar motor? The
data presented here show that DgrA and DgrB are high affinity
receptors for c-di-GMP that, in a ligand-bound form, interfere
with the flagellar motor either directly or indirectly. Motor
control by DgrA-like proteins is not unique to Caulobacter.
Escherichia coli H-NS mutants lack flagella because the expres-
sion of the flagellar master control operon flhCD is reduced.
Ectopic expression of flhCD restores flagellation but leaves the
motors partially paralyzed (24). Under these conditions, f lagel-
lar function can be restored either by a mutation in ycgR, coding
for the E. coliDgrA homolog, or by providing multiple copies of
yhjH, which encodes a presumable c-di-GMP-specific phospho-
diesterase (24). Together with our data demonstrating that the
Salmonella YcgR protein specifically binds c-di-GMP, this find-
ing suggests that in C. crescentus and in enteric bacteria flagellar
motor function might be controlled by c-di-GMP through similar
mechanisms.
But how would DgrA or YcgR interfere with the function of
the flagellum? Our data propose the FliL protein as a candidate
for such a role. FliL was the only flagellar protein that showed
significantly reduced levels in nonmotile cells overexpressing
dgrA. In C. crescentus the FliL protein is not part of the flagellar
structure but is required for flagellar rotation (29). Intriguingly,
fliL mutant strains exhibit a motility phenotype identical to that
of cells that have high levels of c-di-GMP or overexpress dgrA
(29). Because the expression of fliM, the gene located immedi-
ately downstream from fliL in the same operon (30), was not
affected by DgrA, FliL changes must be the result of altered
translation or protein stability. An extragenic suppressor muta-
tion that restored motility under these conditions also reestab-
lished normal FliL concentrations, indicating that the two phe-
notypes are linked. The simplest model that is in agreement with
these results predicts that DgrA, upon binding of c-di-GMP,
represses FliL by a so far unknown mechanism, and through this
mechanism blocks motor function. The extragenic suppressor
mutation restoring FliL levels was mapped to the coding region
of rpsA (ribosomal protein S1). RpsA enhances translation ini-
tiation by binding to mRNA regions upstream from the Shine–
Dalgarno sequence and by tethering the mRNAs on the 30S
subunit of the ribosome (31–33). How DgrA and its ligand
c-di-GMP modulate FliL levels is a subject for future investiga-
tion. Recently, FliL was reported to be involved in surface
sensing and virulence gene expression in the urinary tract
pathogen Proteus mirabilis (34). Thus, it is possible that FliL has
a more general role in controlling the switch between a plank-
tonic and a surface-associated lifestyle.
A bioinformatics study originally proposed that the PilZ domain
is a specific c-di-GMP-binding module (22). This proposal was
recently substantiated by the demonstration that YcgR, a PilZ
protein from E. coli, is able to bind c-di-GMP (23). Here we
presented genetic, biochemical, and structural evidence that further
validates this hypothesis, and we propose amodel for ligand binding
and activation of proteins containing a PilZ domain. NMR studies
with the DgrA homolog PA4608 showed that a dimer of c-di-GMP
binds to a well defined binding site on the surface of the #-barrel
(Fig. 4). Large chemical shift differences between free and ligand-
bound PA4608, which indicate changes in the local environment,
were also observed in both termini of the protein, with the largest
differences observed for residues Arg30–Arg32, Val142, and Ala144.
These regions are structurally ill defined in the absence of ligand
(25) and are probably flexible. The observed chemical shift differ-
ences indicate that these regions come in direct contact with the
ligand after complex formation. The N-terminal part of PA4608
contains three consecutive Arg residues, which are conserved in
most PilZ domains (22) (Fig. 6). Arg side chains are likely to be
involved in hydrogen bonds or in electrostatic or ' stacking
interactions with c-di-GMP, as in the allosteric binding site of the
diguanylate cyclases PleD and DgcA (15, 35). Furthermore, it is
conceivable that the positively charged head groups of Arg are
sufficient for transient binding to the phosphate groups of c-di-
GMP and that their position on the flexible N terminus increases
the ligand capture radius of the protein, as in the ‘‘fly-casting
mechanism’’ proposed in ref. 36.Alternatively, the observed folding
of previously flexible parts of the protein may be responsible for
communication of the c-di-GMP signal to downstream elements,
either by forming new interaction surfaces or by determining the
relative position of neighboring domains. Similarly, the chemical
shift differences of the C-terminal part of PA4608 could be
explained by a specific role in ligand binding. However, the fact that
residues Val142 and Ala144, which showed the largest chemical shift
differences, are not conserved, argues against this possibility.
Several of the motile dgrA loss-of-function suppressors that were
isolated had frameshift mutations in the very C terminus of DgrA
(Fig. 6), suggesting that this part of the protein is critical for its in
vivo function. One possibility is that the C terminus contributes to
the specific readout mechanism of this protein family. Upon
c-di-GMP binding to the #-barrel surface, the C terminus could be
untied to interact with downstream components. In accordance
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Fig. 6. Sequence alignment of the c-di-GMP-binding proteins DgrA, DgrB, YcgR, and PA4608 according to the PilZ Pfam entry PF07238. The PilZ domain is
highlighted in green. DgrA residues shown to be important for c-di-GMP binding and in vivo function (red) and the positions of intragenic dms suppressor
mutations (black) are highlighted above the alignment. Residues of PA4608 with large chemical shift differences upon c-di-GMP binding (blue) are indicated
below the alignment.
4116 ! www.pnas.org"cgi"doi"10.1073"pnas.0607738104 Christen et al.
with such a view, the very C terminus of the P. aeruginosa PilZ
protein has recently been proposed to interact with the PilF protein
required for type 4 pilus assembly (37). To complement our picture
of the c-di-GMP circuitry, future studies will have to focus on
interaction partners of DgrA and related PilZ domain proteins.
It is intriguing that genetic and biochemical studies of the C.
crescentus DgrA protein and structural analysis of PA4608 from
P. aeruginosa identified the same set of key amino acids involved
in c-di-GMP binding (Fig. 6). This finding is a strong indication
that these proteins bind c-di-GMP in a similar way and suggests
that they may share a common signaling mechanism. Based on
these results, we postulate that most or all PilZ domain proteins
function as diguanylate receptor proteins.
Materials and Methods
Strains, Plasmids, and Media. E. coli strains were grown in Luria
broth. C. crescentus strains were grown in complex peptone yeast
extract (38) supplemented with antibiotics, where necessary. For
the exact procedure of strain and plasmid construction, see SI
Materials and Methods.
UV Cross-Linking with C-[33P]di-GMP and Isolation of DgrA. Proce-
dures for enzymatic production of c-[33P]di-GMP and UV
cross-linking with c-[33P]di-GMP were published earlier (6, 15).
For a detailed protocol used for the isolation of DgrA, see SI
Materials and Methods.
Preparation of Isotope-Labeled Protein, NMR Samples, and NMR
Spectroscopy. The detailed procedures for overexpression and
13C,15N labeling of PA4608 are described in SI Materials and
Methods. NMR samples (Shigemi microtubes) were prepared as
0.8 mM U-13C,15N-labeled protein in 300 !l of 95% H2O/5%
D2O/250 mM NaCl/10 mM DTT/1 mM NaN3/10 mM Tris at pH
7.1. C-di-GMP was added at suitable molar ratios from a 7.7 mM
stock solution. NMR spectra were recorded on Bruker (Billerica,
MA) DRX 600 and 800 MHz spectrometers at 293 K with the
exception of EXSY spectra that were recorded at 313 K for faster
exchange. Standard one-, two-, and three-dimensional spectra
were recorded and processed as described elsewhere (39).
Isolation and Mapping of Motile dgrA suppressors. A plasmid car-
rying dgrA (pBBR::dgrA) was conjugated into a C. crescentus
recA mutant strain, and 150 individual transconjugants were
patched onto PYE swarmer plates. Motile dms mutants were
isolated and analyzed by immunoblot with an "-DgrA antibody.
Mutants with reduced DgrA levels were discarded. The rest was
analyzed by retransforming plasmids into the recAmutant strain
to distinguish between intra- and extragenic suppressors. Intra-
genic mutations were identified by sequencing. The extragenic
suppressor (dms0541) was mapped by Tn5 linkage (40) and
cotransduction with phage *CR30, and it was identified by
sequencing.
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Corrections
DEVELOPMENTAL BIOLOGY. For the article ‘‘DMY gene induces male
development in genetically female (XX) medaka fish,’’ by
Masaru Matsuda, Ai Shinomiya, Masato Kinoshita, Aya Suzuki,
Tohru Kobayashi, Bindhu Paul-Prasanth, En-lieng Lau, Satoshi
Hamaguchi, Mitsuru Sakaizumi, and Yoshitaka Nagahama,
which appeared in issue 10, March 6, 2007, of Proc Natl Acad Sci
MEDICAL SCIENCES. For the article ‘‘The omega-3 fatty acid doco-
sahexaenoate attenuates endothelial cyclooxygenase-2 induction
through both NADP(H) oxidase and PKC! inhibition,’’ by
Marika Massaro, Aida Habib, Laura Lubrano, Serena Del
Turco, Guido Lazzerini, Todd Bourcier, Babette B. Weksler,
and Raffaele De Caterina, which appeared in issue 41, October
10, 2006, of Proc Natl Acad Sci USA (103:15184–15189; first
published October 3, 2006; 10.1073!pnas.0510086103), the au-
thors note that the following should be added as an affiliation for
Marika Massaro: Department of Biological and Environmental
Sciences and Technologies, University of Lecce, Ecotekne,
73100 Lecce, Italy. The corrected author and affiliation lines,
and related footnotes, appear below.
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MICROBIOLOGY. For the article ‘‘Specific polysaccharide conjugate
vaccine-induced IgG antibodies prevent invasion of Shigella into
Caco-2 cells and may be curative,’’ by Yehuda Chowers, Joachim
Kirschner, Nathan Keller, Iris Barshack, Simon Bar-Meir, Shai
Ashkenazi, Rachel Schneerson, John Robbins, and Justen H.
Passwell, which appeared in issue 7, February 13, 2007, of Proc
Natl Acad Sci USA (104:2396–2401; first published February 7,
2007; 10.1073!pnas.0610833104), the authors note an error in
the title. The title should read: ‘‘O-specific polysaccharide
conjugate vaccine-induced antibodies prevent invasion of
Shigella into Caco-2 cells and may be curative.’’ The online
version has been corrected. Additionally, on page 2396, in the
first line of the Abstract, in the first line of the second para-
graph of the main text, and in the Abbreviations footnote,
‘‘O-specific polysaccharide’’ should instead appear as ‘‘O-specific
polysaccharide.’’
www.pnas.org!cgi!doi!10.1073!pnas.0702299104
MICROBIOLOGY. For the article ‘‘DgrA is a member of a new family
of cyclic diguanosine monophosphate receptors and controls
f lagellar motor function in Caulobacter crescentus,’’ by Matthias
Christen, Beat Christen, Martin G. Allan, Marc Folcher, Paul
Jeno¨, Stephan Grzesiek, and Urs Jenal, which appeared in issue
10, March 6, 2007, of Proc Natl Acad Sci USA (104:4112–4117;
first published February 27, 2007; 10.1073!pnas.0607738104), on
page 4112, column 1, the key term ‘‘c-di-Ghp’’ should instead
appear as ‘‘c-di-GMP.’’ The online version has been corrected.
www.pnas.org!cgi!doi!10.1073!pnas.0702705104
Table 4. CMV promoter-directed overexpression of DMY and DMRT1
cDNA
Embryos
injected
Embryos
hatched
Hatching
rate, %
XY
male
XX
female
XX
male
DMY 195 86 44.1 20 4 4
DMRT1 139 80 57.6 30 13 0
www.pnas.org!cgi!doi!10.1073!pnas.0702707104
USA (104:3865–3870; first published February 28, 2007;
10.1073!pnas.0611707104), due to a printer’s error, in Table 4,
column 3, the number of DMRT1 embryos hatched was given as
‘‘30’’; it should instead be ‘‘80.’’ Also, in Table 4, column 6,
the number of DMY transgenic XX females was given as ‘‘!4’’;
it should instead be ‘‘4.’’ The corrected table appears below.
www.pnas.org PNAS # May 1, 2007 # vol. 104 # no. 18 # 7729
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SI Figure 7
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SI Materials and Methods
SI Figure 8
SI Figure 9
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SI Figure 7
Fig. 7. Schematic of c-di-GMP signaling. (A) Chemical structure of the bacterial second messenger c-di-
GMP. (B) Synthesis, hydrolysis, and effector mechanism of c-di-GMP. The GGDEF domain harboring
the diguanylate cyclase activity (red), the EAL domain responsible for degradation of the second
messenger into the linear dinucleotide pGpG (blue), and the newly identified diguanylate receptor DGR
(green) are indicated. Dashed lines symbolize product inhibition of diguanylate cyclases by c-di-GMP
(3) and allosteric activation of c-di-GMP-specific phosphodiesterases by GTP (2).
SI Figure 8
Fig. 8. Changes in 1H-15N heteronuclear sequential quantum correlation
spectra of PA4606 upon addition of c-di-GMP. Combined 1H and 15N shift differences (!") between
PA4608 in its free and ligand-bound form, plotted against the amino acid sequence, are shown.
Combined chemical shift differences were calculated as = !([(!"H)
2 + (!"N/5)
2]/2). These data are also
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Combined chemical shift differences were calculated as = !([(!"H)
2 + (!"N/5)
2]/2). These data are also
shown in Fig. 4 with the color codes matching the horizontal lines indicated here.
SI Figure 9
Fig. 9. Secondary 13C# and 13C$ shifts for PA4680 with and without bound c-di-GMP. Secondary shifts
are defined as the difference between observed chemical shifts and chemical shifts of the same atom in
the context of a random coil. Secondary shifts for 13C# and 13C$ atoms in proteins (!C#, !C$) are
mainly determined by secondary structure. In #-helices, !C# = 3.09 ± 1.00 ppm, and !C$ = -0.38 ±
0.85 ppm; in $-sheets, !C# = -1.48 ± 1.23 ppm, and !C$ = 2.16 ± 1.91 ppm (5). In coils, !C# = !C$
= 0 ppm by definition. The amino acid sequence of the PA4608 construct used in this work is shown
with an N-terminal His tag at the top. !C# and !C$ values and secondary structures are indicated for
the free protein (1YWU) and for the ligand bound form. Differences between the two states of the
protein are minimal.
SI Figure 10
Fig. 10. Excerpt from a two-dimensional NOESY spectrum of PA4608 with bound c-di-GMP. The
spectral region shown contains 1H atoms with extraordinarily high chemical shifts on the horizontal axis.
Peaks are labeled where assignments are known; 1H belonging to PA4608 are labeled in black, whereas
1H belonging to c-di-GMP are labeled in red.
Table 2. Purification of c-di-GMP binding proteins from C. crescentus CB15 crude extracts
Sample Total yield of
protein
Total yield of
binding
activity, %
Purification,
fold
Weight, 
µg
Percent
100,000 ´ g supernatant 680,000 100 100 1
60 % (NH4)2SO4
precipitation
323,000 47.5 95 2
Blue Sepharose 0.4-0.7 M
10,800 1.59 40 26
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NaCl
10,800 1.59 40 26
Blue Sepharose 0.7-0.9 M
NaCl
7,800 1.15 41 35
GTP Sepharose 125 mM
NaCl
24 0.0035 11 3,200
SI Materials and Methods
Construction of Strains and Plasmids. In-frame deletions of dgrA and dgrB in Caulobacter
crescentus. Seven hundred base pairs flanking the 3' and 5' DNA regions of both dgrA and dgrB were
PCR-amplified from C. crescentus CB15 genomic DNA using primers 1464, 1465, 1466, 1467, 1472,
1473, 1474, and 1475 (see list below). The PCR products were digested with SpeI and HindIII or with
HindIII and NheI and were subcloned in a triple ligation reaction into the SpeI and NheI sites of vector
pNPTS138 to give pNPTS::dgrA 3-115 and pNPTS::dgrB 3-113. Strains with in-frame deletions in dgrA
or dgrB were constructed by using the suicide plasmids pNPTS::dgrA 3-115 or pNPTS::dgrB 3-113 and
a double-recombination procedure as described (1). The deletion mutants were verified by PCR.
Chromosomal replacement of wild-type drgA with dgrAW75A. The dgrA wild-type gene flanked by a
700-bp 3' and 5' DNA region was PCR amplified from C. crescentus CB15 genomic DNA using primers
1465 and 1466 and cloned into pGEM-T-easy. The point mutations changing Trp75 to Ala were
introduced by a SOE PCR using primers 528, 529, 1585, and 1586. The SpeI- and NheI-digested SOE
PCR product was cloned into the SpeI and NheI sites of vector pNPTS138 to give pNPTS::dgrAW75A.
The suicide plasmid pNPTS::dgrAW75A was then conjugated into a CB15 dgrA strain, and double-
recombinants were selected as described (1). Strains expressing a single copy of dgrAW75A under the
native promoter were screened by PCR and the W75A mutation was confirmed by genomic sequencing.
Plasmids for the overexpression of dgrA and dgrB in C. crescentus. The dgrA and dgrB genes were
PCR-amplified from C. crescentus CB15 genomic DNA by using primer pairs 1460, 1461 and 1468,
1469. The PCR products were digested with KpnI and BamHI and subcloned into the vector
pBBRMCS2 to give pBBR::dgrA or pBBR::dgrB, respectively. Plasmids for the overexpression of dgrA,
dgrB, PA4608, and ycgR in Escherichia coli dgrA and dgrB were PCR-amplified from C. crescentus
CB15 genomic DNA using primer pairs 1462, 1463 and 1470, 1471, digested with NdeI and XhoI, and
cloned into vector pET42b (Novagen, Madison, WI) to give pET42B::dgrA and pET42b::dgrB. PA4806
was PCR-amplified from Pseudomonas aeruginosa PAO1 genomic DNA using primers 1476 and 1477,
and it was digested with NdeI and BamHI and cloned into vector pET15b to produce pET15::PA4608.
ycgR was amplified from Salmonella enterica serovar Typhimurium genomic DNA with primers 1525
and 1526. The PCR product was digested with NdeI and XhoI and cloned into vector pET42b to generate
pET42b::ycgR.
Plasmid for the overexpression of dgcA (CC3285) under Pxyl control in C. crescentus. dgcA was
PCR-amplified from C. crescentus CB15 genomic DNA by using primers 1081 and 1082. The PCR
product was digested with EcoRI and KpnI and subcloned into vector pUJ142 behind the xylose-
inducible promoter Pxyl, resulting in construct pUJ142::dgcA.
Site-directed mutagenesis of dgrA. Primers 1461, 1463, and 1527 were used to replace the dgrA wild-
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type allele with the dgrAD38A allele in plasmids pBBR::dgrA or pET42b::dgrA. An StuI-BamHI
fragment or an StuI-XhoI fragment of dgrA was replaced to give pBBR::dgrAD38A and
pET42b::dgrAD38A. Primers 1461, 1463, and 1528 were used to PCR-amplify the dgrA RR11AA allele,
which was introduced into the vectors pBBRMCS2 and pET42b via KpnI and BamHI or NdeI and XhoI
sites to generate pBBR::dgrAR11AR12A and pET42b::dgrAR11AR12A. Primer pairs 1585, 1463 and
1586, 1462 were used to introduce the W75A point mutation in dgrA by SOE PCR. The PCR product
was digested with NdeI and XhoI and subcloned into vector pET42b to produce pET42b::dgrAW75A.
The dgrAW75A allele was PCR-amplified using primers 1460 and 1461, digested with KpnI and BamHI,
and subcloned into pBBRMCS2 to give pBBR::dgrAW75A.
Primer List.
528 GAC GTT GTA AAA CGA CGG CCA GT.
529 TTT CAC ACA GGA AAC ACG TAT GAC.
1081 AAA GGT ACC TCA AGC GCT CCT GC.
1082 AAA GAA TTC ATG AAA ATC TCA GGC G.
1460 AAG GTA CCG ATG GTC ATG GTC GAG ACC T.
1461 TTG GAT CCT TAG TGA TGA TGA TGA TGA TGG GCG TCG TCT TCG GCG GGC AAA
GTA GCG AGA AAC CGA.
1462 AAC ATA TGG TCA TGG TCG AGA CCT.
1463 TTG GAT CCT TAC TCG AGG GCG TCG TCT TCG GCG GGC AAA GTA GCG AGA AAC
CGA.
1464 AGT AAG CTT GAC GAC GCC TAG AGC GCC TTT CGA TCA GA.
1465 GGC TAG CAG ACC TTC ATC AAC GAA CAC GAC CTC G.
1466 AAC TAG TGT GGA CAG CGC CAG CGT GTG GCT CTG.
1467 CTA AGC TTG ACC ATG ACC ATC CGC TTC TCA AAC C.
1468 AAG GTA CCG ATG TCG AAG CAC GCG TCT GGC GCG GAA CAC G.
1469 TTG GAT CCT TAG TGA TGA TGA TGA TGA TGG CCT GTG GAG ACG TCC GCC CGT
GAC GC.
1470 TTC ATA TGT CGA AGC ACG CGT CTG GCG CGG AAC ACG.
1471 TTG GAT CCT TAC TCG AGG CCT GTG GAG ACG TCC GCC CGT GAC GC.
1472 AGT AAG CTT TCC ACA GGC TGA CGC CCG AGA.
1473 GGC TAG CGC ACT CGC GCC TTG CGG GCG TCG AT.
1474 TAC TAG TTG CCC ACC CTC GCT GAC TAC G.
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1475 CTA AGC TTG TGC TTC GAC ATG GGT CGA TAA ACG CAC.
1476 TCC ATA TGA GTG ACC AGC ACG ACG AAC.
1477 TTG GAT CCT TAG TCG TCG TGG GCG CTG ACC AGC.
1525 CCATATGAGTGGTTACAATGAGCAGTTCC.
1526 CCT CGA GTT CTC GCA CTT TAT TCG CTC TTT C.
1527 AGG CCT CTC TGC TGG CGG TCG CCG AGA AGG GCG GGC GGA TCT CCA T.
1528 CAT ATG GTC ATG GTC GAG ACT AGT GGC GCT GAG GCA GCC GCG CAT CCC C.
1585 ATC TCG CCA ACG TCG TCG CAC GCT CCG GGA CCG AGG TC.
1586 ACC TCG GTC CCG GAG CGT GCG ACG ACG TTG GCG AGA T.
Lysis and Ammonium Sulfate Precipitation. A total of 12.44 g of C. crescentus CB15 cell pellet was
resuspended in 110 ml of ice-cold 1´ PBS buffer A containing 10% (vol/vol) glycerol, 1 mM DTT, 1
tablet COMPETE protease inhibitor (Roche, Indianapolis, IN), and sonicated for 5 min on ice. The lysate
was centrifuged at 10,000 ´g for 20 min at 4°C, and the supernatant was harvested and centrifuged at
100,000 ´ g for 60 min. The soluble protein fraction was saturated to 30% (NH4)2SO4 at 4°C, and the
30% precipitate was removed by an additional centrifugation step at 100,000 ´g for 1 h at 4°C. The pellet
was discarded, and the remaining supernatant was saturated to 60% (NH4)2SO4. The precipitate was
collected by centrifugation at 100,000 ´g for 1 h at 4°C, resuspended in 50 ml of buffer A, and dialyzed
overnight using a SpectraPor dialysis membrane cutoff of 8 kDa (Spectrum, Rancho Dominguez, CA).
Synthesis of GTP-Sepharose 4B Column. A total of 550 mg of epoxy-activated Sepharose 4B
(Sigma-Aldrich, St. Louis, MO) was washed with 100 ml of H2O for 30 min. The matrix was
resuspended in 2.5 ml of 0.5 mM NaOH, and 36.4 mg of GTP (Amersham Pharmacia, Piscataway, NJ)
was added. After the reaction mixture was shaken for 72 h at 25°C, the Sepharose was collected by
centrifugation. UV absorption measurements at 254 nm before and after the reaction revealed that 9.92
mg of GTP was bound to the matrix. The matrix was blocked with 20 ml of 1 M ethanolamine (pH 8.0)
for 1 h at 25°C. Unbound GTP and ethanolamine was removed by washing with three cycles of 10 ml of
H2O/10 ml of acetate buffer, pH 4.0/500 mM NaCl/10 ml of Tris buffer, pH 8.0/500 mM NaCl.
Blue Sepharose CL-6B Column. Fifty milliliters of resuspended and dialyzed 60% (NH4)2SO4
precipitate containing 323 mg of protein (6.63 mg/ml) was loaded on a Blue Sepharose CL-6B column
(Amersham Pharmacia) (flow, 2 ml/min; 30 ml resin) with buffer A as loading buffer [1´ PBS buffer A
containing 10% (vol/vol) glycerol/1 mM DTT]. Protein (151 mg) was collected in the flow-through, and
an additional 160 mg was eluted during washing with 200 ml of buffer A. Bound proteins were eluted
with a gradient of 50-1,000 mM NaCl at a flow rate of 3 ml/min. The following fractions were pooled,
dialyzed overnight in buffer A, and concentrated to a final protein concentration of 1 mg/ml by using a
50-ml Amicon ultrafiltration cell and regenerated cellulose ultrafiltration membrane NMWL 10,000
(Millipore Corporation, Billerica, MA): weak binders (3.3 mg of protein, fractions 7-11), medium
binders (10.8 mg of protein, fraction 12-20), and tight binders (7.8 mg of protein, fractions 21-29).
GTP-Sepharose 4B Column. Three milliliters of the concentrated tight-binder fraction from the Blue
Sepharose column was loaded on a 500-ml GTP-Sepharose 4B affinity resin in a 15-ml spin column and
incubated for 5 min at 4°C. The loading was removed by centrifugation at 800 rpm in a tabletop
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centrifuge for 2 min, and the flow-through was collected and stored on ice. The column was washed four
times with 2 ml of buffer A, and the bound proteins were eluted by sequentially adding 2 ml of buffer A
with 125, 250, 500, and 1,000 mM NaCl. Fractions eluted from the GTP-Sepharose 4B column were
washed with buffer A in 1-mm centrifugal filter devices (Millipore Corporation) and concentrated to a
final volume of 250 ml.
33P-Labeled c-di-GMP. 33P-labeled c-di-GMP was produced enzymatically using [33P]GTP (3,000
Ci/mmol) and purified as described earlier (2, 3). Nickel-nitrilotriacetic acid-purified protein samples or
C. crescentus CB15 protein preparations were incubated for 10 min on ice in PBS buffer supplemented
with 1 mM DTT/1 mM c-di-GMP/33P- radiolabeled c-di-GMP (0.75 mCi, 6,000 Ci/mmol). Samples
were irradiated at 254 nm for 20 min in an ice-cooled, Parafilm-wrapped, 96-well aluminum block in an
RPR-100 photochemical reactor with a UV lamp RPR-3500 (Southern New England Ultraviolet
Company, Branford, CT). After irradiation, samples were mixed with 2´ SDS/polyacrylamide sample
buffer [250 mM Tris·HCl, pH 6.8/40% (vol/vol) glycerol/8% SDS/b2-mercaptoethanol/0.06%
bromophenol blue/40 mM EDTA] and heated for 5 min at 95°C. Labeled proteins were separated by
SDS/PAGE using 12.5% acrylamide gels or Tris/Tricine gradient gels and quantified by autoradiography.
Bands corresponding to c-di-GMP-binding proteins were cut from the gels and were identified by
MS/MS using a LTQ Orbitrap mass spectrometer (Finnigan, San José, CA). The nucleotide composition
of the sample was analyzed by PEI-cellulose chromatography to exclude enzymatic cleavage of c-di-
GMP during the UV cross-linking procedure.
Determination of the c-di-GMP-Binding Constant for Diguanylate Receptor Proteins. Binding
constants were determined by performing UV cross-linking experiments with 50 ml of 50 nM His tag-
purified diguanylate receptor protein and 0.02 mg/ml BSA in the presence of 0, 50, 100, 200, 375, 500,
750, and 1,000 nM 33P-labeled c-di-GMP. Samples were separated by SDS/PAGE and stained with
colloidal Coomassie blue. The gel was dried and exposed on a storage PhosphorImaging screen
(Molecular Dynamics, Eugene, OR). Incorporation was measured by quantifying the intensities of the
relevant spots using ImageJ software version 1.33 (National Institutes of Health, Bethesda, MD).
Incorporation was plotted against the c-di-GMP concentration, and Kd values were determined with the
Software Pro Fit 5.6.7.
Preparation of Isotope-Labeled Protein. E. coli strain BL21 (Novagen) carrying the pET15::PA4608
expression plasmid was grown in 3 liters of minimal medium containing 1.5 g of 15NH4Cl and 4.8 g of
unlabeled or 13C-labeled glucose as sole nitrogen and carbon sources. Protein expression was induced
with 0.4 mM IPTG for 3 h. PA4608 was purified by nickel-nitrilotriacetic acid affinity chromatography
(Qiagen, Valencia, CA) followed by size-exclusion chromatography using an Amersham Pharmacia
HiLoad 26/60 Superdex 75 column.
NMR Samples and NMR Spectroscopy. NMR samples (Shigemi microtubes) were prepared as 0.8 mM
U-13C/15N-labeled protein in 300 µl of 95% H2O/5% D2O with 250 mM NaCl/10 mM DTT/1 mM
sodium azide/10 mM Tris at pH 7.1. C-di-GMP was added at suitable molar ratios from a 7.7 mM stock
solution. NMR spectra were recorded on Bruker DRX 600 and 800 MHz spectrometers at 293 K (20°C)
with the exception of EXSY spectra that were recorded at 313 K for faster exchange. Standard one-, two-
, and three-dimensional spectra were recorded and processed as described elsewhere (4).
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PA4608 · c-di-GMP structure, page E-1
Solution structure of the diguanylate receptor
PA4608 with bound c-di-GMP
*
Martin G. Allan, Matthias Christen, Beat Christen, Regula Aregger, Urs Jenal and
Stephan Grzesiek
Biozentrum, Universität Basel, Switzerland
Abstract
Cyclic di-guanosine monophosphate (c-di-GMP) is a bacterial second messenger
molecule that controls the switch from a planktonic, single-cell lifestyle to surface-
attached, multicellular communities such as biofilms. The natural receptors of c-di-
GMP have recently been found to be members of a domain family named PilZ. We
have solved the solution structure of the PilZ domain protein PA4608 in complex with
its ligand c-di-GMP by NMR spectroscopy. C-di-GMP binds to the side of the
PA4608 !-barrel as an intercalated dimer. The previously flexible, N-terminal RxxxR
motif of the protein contacts the bound ligand, which in turn displaces two C-terminal
310 helices. We propose that this movement of the termini of the protein forms the
basis of the molecular mechanism by which ligand binding elicits downstream
responses.
                                                 
* Author contributions: MGA prepared NMR samples, recorded, processed and evaluated NMR
spectra, calculated the structure, and wrote the report. MC, BC, RA and UJ produced and purified
isotope-labeled c-di-GMP and PA4608. SG supervised the structure determination.
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Introduction
Cyclic di-guanosine monophosphate (c-di-GMP) is a second messenger molecule that
appears to be ubiquitous in, and also unique to, the bacterial kingdom. Elevated
intracellular levels of c-di-GMP generally cause bacteria to change from single,
motile cells to surface-attached multicellular communities. In Gluconacetobacter
xylinum (formerly Acetobacter xylinum), c-di-GMP activates cellulose synthase;1 in
Caulobacter crescentus, it is involved in the transition from flagellated swarmer cells
to surface-attached stalked cells;2 in Vibrio cholerae, it regulates biofilm formation
and the expression of virulence genes;3 and in Pseudomonas aeruginosa, it is required
for alginate biosynthesis.4
C-di-GMP consists of two guanosine moieties that are symmetrically connected by 5'-
3' phosphodiester bonds, forming a 12-membered ring (Figure 1a). C-di-GMP has
been shown to be extraordinarily polymorphic: five different solution structures
ranging from monomer to octamer have been described.5 An X-ray crystal structure of
c-di-GMP6 reveals a compact, self-intercalated dimer structure that is stabilized by
base stacking and two hydrogen bonds between a H1 atom of one monomer, and a
phosphate oxygen of the other (Figure 1b). A very similar self-intercalated structure
was also observed in the crystal structure of PleD, which contained two allosterically
bound dimers of c-di-GMP besides the extended, monomeric c-di-GMP molecule
bound to the active site7 (PDB 1W25).
C-di-GMP is produced from GTP by diguanylate cyclase (DGC) enzymes containing
GGDEF domains, and degraded to pGpG by phosphodiesterases (PDE) containing
EAL domains. One or several of each of these domains are found in virtually all
bacteria.
The long elusive natural receptor proteins of c-di-GMP were recently identified in
silico. Based on its context in multidomain proteins including proteins known to be
regulated by c-di-GMP, and on its occurrence in genomes that also contain GGDEF
and EAL domain proteins, the PilZ domain was proposed as a c-di-GMP receptor.8
Biochemical studies on overexpressed Escherichia coli proteins confirmed that PilZ
proteins indeed bind c-di-GMP with high affinity.9 Independently, c-di-GMP
receptors were isolated from C. crescentus using biochemical methods, by probing for
c-di-GMP binding, and identified by mass spectrometry.10 C-di-GMP binding to PilZ
domains has since been shown by several groups.3,11
The structures of two PilZ proteins had been solved by structural genomics initiatives
before their function became known. The crystal structure of VCA0042 from Vibrio
cholerae
12 (PDB 1YLN) reveals two six-stranded !-barrel domains, the C-terminal
one of which shows good sequence homology to other PilZ domains. The solution
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structure of PA4608 from P. aeruginosa11 (PDB 1YWU) contains a single PilZ
domain. Its N-terminal part comprising residues M23-R35, which contain the
signature RxxxR motif found in the vast majority of PilZ domains, is dynamic and
disordered.
We here present the solution structure of PA4608 with bound c-di-GMP.
Materials and methods
Production and purification of PA4608
Cloning and transformation. The PA4608 gene was amplified from P. aeruginosa
strain PAO1 genomic DNA by PCR, digested with the restriction enzymes NdeI and
XhoI, and cloned into vector pET15b. A hexahistidine tag followed by a short linker
including a thrombin cleavage site (MGSSHHHHHHSSGLVPRGSH) precede the
PA4608 sequence. The pET15::PA4608 plasmid was transformed into E. coli strain
BL21 by electroporation, and the resulting strain was named BC1015. Bacteria were
grown in 1.15 L of a modified M9 medium containing 0.5 g 15NH3 and 2.0 g 
13C6-
glucose as sole sources of nitrogen and glucose, respectively; the composition was
100 mL 10 " phosphate buffer (130 g KH2PO4, 100 g K2HPO4, 227 g Na2HPO4 · 12
H2O, ad 1 L H2O, pH adjusted to 7.2); 0.45 g 
15NH4Cl; 1.8 g 
13C6-glucose; 4.75 mL
1M MgCl2 ; 4.75 mL trace elements mixture [41 mM CaCl2, 22 mM FeSO4 , 5.8 mM
MnCl2, 5.8 mM CoCl2; 2.4 mM ZnSO4, 1.8 mM CuCl2, 0.32 mM H3BO3, 0.20 mM
(NH4)2Mo2O7, 12 mM EDTA]; 100 mg ampicillin sodium salt; ad 1 L H2O. Cells
were grown to an OD600nm of 0.8 in shaking flasks at 37°C. PA4608 expression was
induced by addition of IPTG to a final concentration of 0.4 mM, and maintained for 2
h at 37°C. Cells were harvested by centrifugation at 4000 rpm and 4°C for 20 min.
The wet weight of the cell pellet was approximately 8 g. Cells were resuspended in
about 30 mL Phosphate Buffered Saline (PBS; 80 g NaCl, 2.0 g KCl, 14.4 g
Na2HPO4, 2.4 g KH2PO4, ad 1 L H2O, pH about 7.4) and stored at –20°C until further
processing.
Cell rupture & fractionation. The cell pellet was thawed, and cells were disrupted
using a FA-031 FRENCH pressure cell (Spectronic Unicam) at approximately 1200
bar. This and all subsequent steps were carried out at 4°C. The suspension was
centrifuged for 18 min at 6400 rpm, and the pellet was discarded. The supernatant was
again centrifuged at 30000 rpm for 48 min, and the pellet discarded.
Nickel affinity chromatography. Cell lysate was incubated with 2 mL Ni-NTA
Superflow resin (Qiagen) for 1 h. Two 15 mL batch columns (Promega) were loaded
with the mixture, and packed by centrifugation at 3200 rpm. Each column was
washed with 10 mL PBS, followed by 10 mL PBS containing 10 mM imidazol and 10
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mL PBS containing 50 mM imidazol. The protein was then eluted with 8 mL PBS
containing 250 mM imidazol per column. 2 mL fractions were collected, and their
protein content was assessed by SDS-PAGE using the Amersham PhastGel system:
small amounts of eluate were mixed with loading buffer (10% (v/v) glycerol, 5% (v/v)
!-mercaptoethanol, 3% (w/v) SDS, 130 mM Tris-HCl at pH 6.8, 0.2 g/L bromophenol
blue) at a ratio of 1:1 and separated on homogenous 20% polyacrylamide gels, which
were stained with Coomassie Brilliant Blue. Fractions containing PA4608 protein
were pooled and concentrated to a total volume of 8 mL using a 20 mL Vivaspin
concentrator.
Size exclusion chromatography. The elution buffer used for size exclusion
chromatography contained: 10 mM Tris-HCl at pH 7.0; 250 mM NaCl; 10 mM
dithiothreitol (DTT).  The protein solution was loaded on a HiLoad 26/60 Superdex
75 size exclusion column connected to an FPLC system (Amersham), and eluted at a
flow rate of 2 mL/min. 5 mL fractions were collected, and UV absorption of the
eluate at 280 nm was monitored. PA4608 eluted as a single, large peak at an elution
volume of 190-210 mL.
Assessment of purity and yield. The homogeneity of the protein solution was tested by
SDS-PAGE as decribed above. No contaminant protein bands were detected. A 1H-
15N-HSQC NMR spectrum of the preparation was recorded, and was found to be in
good agreement with previously recorded reference spectra; no significant
contaminant peaks were detected. The extinction coefficient of PA4608 was estimated
as 17990 AU/M/cm, and the molecular mass was calculated as 16.737 kDa, with the
ExPASy tool.13 UV absorption spectra of a 1:10 dilution of the protein solution in
water were recorded, and the total protein yield was determined to be 23.4 mg.
Production and purification of c-di-GMP
C-di-GMP was produced enzymatically from GTP, using a not feedback-inhibited
mutant of the diguanylate cyclase DgcA named DgcA0646, in which the inhibition
site RESD was replaced with GRDC.14
Production and purification of DgcA0646. E. coli strain BL21 carrying the plasmid
pET42b::dgcA0646 was grown at 37°C in 1.5 L LB medium containing 0.6 mM
kanamycin in shaking flasks. Protein expression was induced at OD600nm 0.9 by
addition of IPTG to a final concentration of 0.4 mM, and maintained for 2 h. Cells
were harvested by centrifugation and disrupted using a type FA-031 French press
(Spectronic Unicam). Cell debris was removed by centrifugation, and the supernatant
was incubated with 800 µL Ni-NTA Superflow resin (Qiagen) at 4°C for 1 h. 15 mL
batch columns (Promega) were loaded with the mixture, and packed by centrifugation
at 3200 rpm. Each column was washed with 10 mL PBS, followed by 10 mL PBS
containing 10 mM imidazol and 10 mL PBS containing 50 mM imidazol. The protein
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was eluted with 8 mL PBS containing 250 mM imidazol. 2 mL fractions were
collected, and their protein content was assessed by SDS-PAGE. The protein yield
was assessed using the Bio-Rad protein assay; 6 mg were obtained.
Production and purification of c-di-GMP. 6 mL 1 mM DgcA0646 was incubated with
0.6 mL 1 mM GTP, 50 mM MgCl2, 20 mM Tris-HCl (pH 8) at 30°C for 1.5 h. The
mixture was centrifuged at 13000 rpm for 5 min to remove precipitated enzyme, and 1
mL fresh 1 mM DgcA0646 was added to the supernatant. The mixture was incubated
at room temperature overnight. Protein was removed by addition of 150 µL Ni-NTA
Superflow resin (Qiagen) and incubation at 4°C for 20 min, followed by
centrifugation. The supernatant was loaded on a C18 reverse phase HPLC column,
and eluted with a 25 ml gradient from 5 to 30% methanol in 250 mM
triethylammonium carbonate (TEAC), pH 7 in water. The flow rate was 1 mL/min. C-
di-GMP eluted after 20.2 min as a single, sharp peak, and was collected based on UV
absorption at 254 nm. The c-di-GMP solution was lyophilized at <1 mbar. In order to
remove residual TEAC, c-di-GMP was redissolved in 600 µL H2O and lyophilized
again. The yield was measured by UV absorption at 252 and 260 nm and was found to
be 1.3 µmol, or 920 µg; an extinction coefficient of 28.18 AU/mM/cm at 252 nm was
assumed, based on guanosine monophosphate.15 C-di-GMP labeled with 13C and 15N
was produced in the same manner, starting with 13C-, 15N-GTP (Spectra Stable
Isotopes).
NMR sample preparation
Protein samples. PA4608 sample buffer contained 250 mM NaCl, 10 mM Tris-HCl at
pH 6.7, 0.01% (w/v) NaN3 as a preservative, and 5% (v/v) D2O for locking. The
protein concentration was 0.8 – 1.2 mM, and the sample volume was 200 – 400 µL.
Samples were put in NMR microtubes with their magnetic susceptibility matched to
D2O, with an outer diameter of 5 mm (Shigemi, Inc.).
Protein-ligand complex samples. C-di-GMP was added to PA4608 samples in NMR
tubes as an approximately 19 mM solution. 1H-15N HSQC spectra were recorded to
monitor the fraction of protein with bound ligand; two equivalents of c-di-GMP were
necessary to saturate the protein. The sample pH, which was lowered after addition of
acidic c-di-GMP, was readjusted by adding concentrated NaOH; the sample pH was
followed using a pH meter and by observing histidine N#1 and N$2 chemical shifts in
long-range 1H-15N HSQC spectra.
D2O samples. H2O samples were transferred to 1.5 mL polypropylene tubes, shock
frozen in liquid nitrogen, and lyophilized at <1 mbar. The lyophilisate was
redissolved in D2O. This process was repeated once. The sample was transferred to a
Shigemi tube that had been rinsed with D2O and dried.
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Oriented sample for measurement of RDCs. The oriented sample had a final volume
of 290 µL and contained: 0.5 mM PA4608; 1.0 mM c-di-GMP; 56 mM NaCl; 20 mM
Tris-HCl at pH 6.7; 0.01% (w/v) NaN3; 5% (v/v) D2O; and 18 g/L Pf1 phage (Asla
Biotech).
The following samples were prepared:  uniformly 13C- and 15N-labeled protein with
unlabeled c-di-GMP in H2O and D2O; uniformly 
13C- and 15N-labeled protein with
13C- and 15N-labeled c-di-GMP in H2O, D2O, and H2O plus Pf1 phage for
measurement of RDCs; and 15N-labeled protein with less than one equivalent of
unlabeled c-di-GMP for exchange spectroscopy (EXSY).
NMR spectroscopy
Standard 1-, 2- and 3D NMR spectra similar to those described in Grzesiek & al.,
199716 were recorded on Bruker DRX 600 and DRX 800 NMR spectrometers with
TXI and TCI probe heads, respectively. The sample temperature was 293 K except
where indicated otherwise. A list of NMR spectra is given in Table 1. NMR data were
processed using the NMRPipe suite of programs.17
Resonance assignments
Protein resonances were assigned using standard techniques.16
C-di-GMP ribose resonances were connected using 13C-resolved 3D COSY and
TOCSY spectra recorded on 13C-, 15N-labeled c-di-GMP bound to 13C-, 15N-labeled
PA4608. Ribose moieties and guanine H1/N1 and H8/C8 resonances were assigned to
c-di-GMP molecules based on NOE contacts.
Structure calculations
Conformational restraints. Cross peaks in 3D NMR spectra were assigned using the
program STAPP,18,19 and assignments were iteratively refined based on preliminary
structure calculations. Backbone torsion angle restraints were derived from 13C% and
13C! chemical shifts using the program TALOS.20 Side chain &1 torsion angles were
obtained from HN-H! ROE distances and 3JH%H!, 
3JNC' and 
3JC'C' coupling constants.
Hydrogen bonds were included as distance restraints between HN and O and between
N and O atoms where hydrogen bond donors and acceptors could be unambiguously
assigned after preliminary structure calculations. Analysis of 3JHH couplings in c-di-
GMP ribose moieties revealed that all four ribose moieties were in a 3'-endo
conformation; accordingly, five torsion angle restraints were introduced for each
ribose ring. 29 protein-ligand NOE contacts were observed in 2D, isotope-filtered 2D
and 13C-edited 3D NOESY spectra. 11 13C-1H RDCs were measured for c-di-GMP
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ribose moieties. Comprehensive statistics on conformational restraints are given in
Table 2.
Structure calculations. Structure calculations were performed with the program
XPLOR-NIH21 using a slightly modified version of the annealing protocol “sa.inp”
included therein. C-di-GMP molecules were defined as two-residue, circular strands
of RNA using parameters from the XPLOR-NIH file nucleic.par. The 20 residue His
tag and linker was not included in structure calculations. Statistics for the complex
structure are given in Table 2.
Kinetic measurements. The rates of disappearance of the free protein species and of
appearance of protein with bound c-di-GMP were measured by continuously
recording 1D 1H spectra of PA4608 for 2.5 h after adding c-di-GMP and mixing. Each
spectrum was recorded for 1.5 min. Steady-state association and dissociation rates
were measured with a 3D 1H-15N EXSY spectrum recorded at a temperature of 313 K;
exchange was not detectable at 293 K.
Results and discussion
Resonance assignments
Resonance assignments were found for roughly 90% of the protein backbone in the
PA4608 · c-di-GMP complex. Two stretches of the sequence, F33-I36 and D130-
L138, were not visible in NMR spectra; presumably these residues are mobile, and
NMR signals are broadened beyond detection by intermediate exchange. This
situation did not improve after cooling to 278K or heating to 303 or 313 K. In protein-
bound c-di-GMP, all imino H1 and carbon-bound hydrogens were assigned except for
Gua1 H5'' and Gua4 H4', H5', and H5''. Assignment statistics are given in Table 2.
Secondary 
13
C% and 
13
C! shifts
Secondary 13C% and 13C! chemical shifts, i.e. observed chemical shifts minus chemical
shifts expected in a random coil, are shown in Figure 2. Secondary 13C% and 13C!
chemical shifts are primarily defined by secondary structure.22 Thus for residues I36-
L128, i.e. the ! barrel plus helix %1, the secondary structure of PA4608 with bound c-
di-GMP is identical to that of the free protein. The N-terminus up to residue E29 is a
random coil in both free and ligand-bound protein; resonance assignments are
incomplete for R31-I36. The region constituting helix 310 1 in free PA4608 and
comprising residues G129-E137 could not be observed in the PA4608 · c-di-GMP
complex, indicating that it becomes more flexible after ligand binding. The C-
terminal residues A139-S143, which form helix 310 2 in free PA4608, have different
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secondary 13C% and 13C! chemical shifts in the complex, implying that structural
rearrangement takes place at the C-terminus.
Kinetics of association and dissociation
In order to follow the association reaction of c-di-GMP with PA4608, 1D 1H NMR
spectra of the reaction mixture were recorded continuously after mixing the two
components. Peaks corresponding to ligand-bound protein appeared surprisingly
slowly, on a time scale of about 100 min. Peaks corresponding to unbound protein
disappeared at the same rate. Several peaks were attributed to free c-di-GMP. One set
with chemical shifts of 11.08 and 11.14 ppm disappeared at a slightly faster rate than
free protein, while another set with chemical shifts of 11.27 and 11.29 ppm increased
in intensity for approximately 10 minutes before disappearing again, at a rate
comparable to free protein resonances. Considering that upon mixing c-di-GMP stock
solution with protein sample, c-di-GMP is transferred from a concentrated, acidic
solution to a more dilute, buffered environment, we suggest that the observed slow
processes represent a rearrangement of c-di-GMP to a form that is suitable for binding
to PA4608. It has been reported previously that the transition between different states
of c-di-GMP can be very slow and take up to several hours to complete.5
The PA4608 · c-di-GMP structure
The structure of the PA4608 · c-di-GMP complex was solved using a total of 1521
conformationally restricting constraints, including 1150 distance restraints as well as
RDC, hydrogen bond, TALOS, and &1 angle constraints. The position and
conformation of the ligand was defined by 11 13C-1H RDCs in ribose moieties, 29
NOE contacts between protein and ligand, and 56 NOE contacts within or between
ligand molecules. The rmsd coordinate precision of the final model was 0.34 Å for
backbone atoms of residues in the ! barrel, 0.97 Å for all non-hydrogen atoms in the
structured part of the protein (residues F38-N127), and 1.98 Å for non-hydrogen
atoms in c-di-GMP. Figure 5 illustrates the model precision. Detailed statistics on
conformational restraints and model quality are give in Table 2.
The PA4608 · c-di-GMP complex structure is shown in Figure 6. C-di-GMP binds to
the side of the PA4608 ! barrel. The N-terminal part comprising residues M23-R35
appears to be flexible and unstructured: 13C% and 13C! chemical shifts are indicative of
a random coil conformation (Figure 2), and no long-range protein-protein NOE
contacts were found. Four NOE contacts were identified, however, between c-di-
GMP residue Gua3 and protein residues R30-R32 (Figure 4). Thus the N terminus
containing the highly conserved RxxxR motif contacts the bound ligand on its distal
side. The position of these residues could only be determined with moderate precision
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as residues F33-R35 were not observable in NMR spectra because of unfavorable
dynamics.
Residues G129-E137 could not be observed in PA4608 · c-di-GMP, again because
these residues were mobile. Residues L138-D147 contained a large number of short
range NOEs indicating that residues L139-S143 form an % helix containing. However,
no long-range contacts between this C-terminal helix and the ! barrel were identified,
and no structural information is available for residues D130-E137; therefore the
position of the C-terminal % helix relative to the ! barrel could not determined.
C-di-GMP binds to PA4608 as an intercalated dimer
Four sets of guanosine resonances with similar intensity and relaxation properties
were observed in NMR spectra of PA4608 · c-di-GMP, implying that the complex
contains two molecules of c-di-GMP. Four sets of NOESY peaks originating from c-
di-GMP imino H1 atoms are shown in Figure 3. Many NOE contacts were observed
between c-di-GMP Gua4 H1 and the ribose moieties of Gua1 and Gua2, and between
Gua4 H1 and the ribose moieties of Gua1 and Gua2 (Figure 4), consistent with the
previously observed self-intercalated structure of free c-di-GMP.6,7 From this
structure, contacts were also expected between Gua3 H1 and the ribose moiety of
Gua1, and between Gua2 H1 and the ribose moiety of Gua4. However, the guanine
moiety of Gua3 is dynamic as inferred from NMR peak shapes; consequently,
NOESY diagonal and cross peaks were weak (Figure 3). The ribose moiety of Gua2
appears to be displaced from the c-di-GMP stack by the side chain of W99 and is too
far away from the ribose moiety of Gua4 for NOE transfer to occur.
Dynamics
15N relaxation data for free and ligand-bound PA4608 are shown in Figure 8.
Transverse (T2) and longitudinal (T1) relaxation time constants indicate that the
overall tumbling rate increases slightly after ligand binding, presumably because the
previously flexible N-terminus folds around the bound ligand, reducing hydrodynamic
drag. This is supported by all relaxation parameters measured for residue R30, where
the {1H}-15N NOE rate and 15N T1 are drastically increased, whereas 
15N T2 is
reduced such that all parameters are comparable to the core of the protein after ligand
binding. Residue W99, which is in direct contact with bound c-di-GMP, is less
flexible in the ligand-bound state. The C-terminal part of the protein comprising
residues residues V142-D147 becomes more flexible after ligand binding.
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Comparison of free and ligand-bound PA4608
An overlay of free and ligand-bound PA4608 is shown in Figure 7. Helix %1 appears
to tilt towards the ! barrel by approximately 12°; however, considering the very
similar 13C% and 13C! chemical shifts in this region (Figure 2) we believe this to be an
artifact of structure determination. More importantly, free PA4608 contains two C-
terminal 310 helices that contact the ! barrel. In PA4608 · c-di-GMP, residues D130-
L138 were not observed in NMR spectra, and the only available structural
information about this region is that it has a certain flexibility. Residues A139-A144
form an % helix whose position relative to the ! barrel remains unknown; this helix
cannot take the place of helix 310 2 in free PA4608 since that position is occupied by
the bound ligand.
Biological context
After recognition of c-di-GMP by PA4608, the signal must be further relayed to
downstream effectors to elicit a response in vivo. The interaction partners of PA4608
remain unknown; we can only assume that they recognize interaction surfaces formed
in PA4608 after ligand binding. Unlike PA4608, many PilZ domains are parts of
larger multidomain proteins. In such a context, the formation of additional structure in
the N-terminus and rearrangement of the C-terminus of the PilZ domain described
here may change the interactions of output domains, and thus elicit downstream
responses.
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 Figures and Tables
Table 1: NMR spectra recorded on PA4608 · c-di-GMP.
Experiment Samplea time
Acquisition times in
indirect dimensions(ms)
1H freq.
(MHz)
Purpose
1H-15N HSQC 1 N: 60 600 Overview
Aliphatic constant-time 1H-13C
HSQC
1 C: 26.0 800 Overview
Aromatic 1H-13C HSQC 1 C: 12.4 800 Overview
Constant-time HNCO23 with
WATERGATE24
1 11 h C': 39.2; N:27 600 Overview
HNCA25,26 1 37 h C: 10.8; N: 23.4 600 Assignments
CBCANH27 1 36 h C: 6.8; N: 22.9 600 Assignments
CBCA(CO)NH28 with
WATERGATE24
1 35 h C: 6.8; N: 25.6 600 Assignments
C(CO)NH TOCSY28 1 40 h C: 7.0; N: 25.6 600 Assignments
HBHA(CO)NH29 with
WATERGATE24
1 49 h H: 11.0; N: 25.6 600 Assignments
Aliphatic HCCH TOCSY30,31 1 37 h H: 15.6; C: 10.0 800 Assignments
Ribose HCCH TOCSY 3 37 h H: 16; C: 5.2 600
Ribose
assignments
Ribose HCCH COSY 3, 303 Kb 20 h H: 15.4; C: 6.1 600
Ribose
assignments
HAHB32 2 32 h H%H!: 9.9; C%: 23.6 800
3JH%H!
couplings
HAHB32 optimized for ribose 3J
couplings
3
/ 4
46 h
/ 47 h
H: 12.2; C: 14.5
H: 6.9; C: 14.5
800
Ribose 3JHH
couplings &
RDCs
13C'-{13C'} spin-echo difference
1H-15N HSQC33
5 20 h N: 50 600
aromatic
3JC'C'
couplings
15N-{13C'} spin-echo difference
1H-15N HSQC33
5 20 h N: 59.8 800
aromatic
3JC'C'
couplings
Methyl C 2 16 h C: 51.2 600
methyl 3JC'C'
couplings
Methyl N 2 28 h C: 51.2 600
methyl 3JNC'
couplings
15N-edited 3D ROESY 5 47 h H: 15.0; N: 23.9 800
ROE
distances
15N-edited 3D NOESY with
water flip-back,34 radiation
damping during mixing period35
1 33 h H: 14.4; N: 20.3 800
NOE
distances
Aliphatic 13C-edited 3D
NOESY36,37
1 53 h H: 15.1; Caliph.: 9.9 800
NOE
distances
Aromatic 13C-edited 3D NOESY 1 51 h H: 15.3; Carom.: 8.0 800
NOE
distances
Ribose 13C-edited 3D NOESY 5 61 h H: 10.2; Cribose: 6.0 800
NOE
distances
4D 13C-13C-NOESY-HMQC 2 94 h C1: 5.0; H1: 8.0; C2: 5.0 800
NOE
distances
2D NOESY 1 19 h H: 23.3 600
c-di-GMP
H1 NOEs
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2D NOESY filtered against 1H
bound to 13C or 15N
1 11 h H: 23.3 600
c-di-GMP
H8 NOEs
2D NOESY filtered against 1H
bound to 13C or 15N, without
decoupling in indirect dimension
1 6 h H: 23.3 600
Distinguish
protein and
c-di-GMP in
indirect
dimension
2D NOESY filtered against 1H
bound to 13C or 15N
2 9 h H: 23.3 600
c-di-GMP
H1' NOEs
IPAP 1H-15N HSQC
1
/ 4
6 h
/ 1.5 h
N: 76.8 800 N-HN RDCs
J-resolved constant-time 13C-
HSQC
5
/ 4
7h
/ 11 h
J: 22.5; C: 23.5
/ J: 22.7; C: 23.5
800
Ribose C-H
RDCs
2D 1H-resolved 15N EXSY
6, 293 K
/ 303 K
/ 313 K
16 h
/ 13 h
/ 15 h
H: 15.9 600
Exchange
rates
3D 1H-, 15N-resolved 15N EXSY 6, 313 K 47 h H: 17.0; N: 43.2 800
Assignments,
exchange
rates
a The sample temperature was 293 K unless indicated otherwise. The following samples were used:
1: 13C-, 15N-protein + unlabeled ligand in H2O;
2: 13C-, 15N-protein + unlabeled ligand in D2O;
3: 13C-, 15N-protein + 13C-, 15N-ligand in D2O;
4: 13C-, 15N-protein + 13C-, 15N-ligand in H2O + Pf1 phage;
5: 13C-, 15N-protein + 13C-, 15N-ligand in H2O;
6: 15N-protein + approx. 0.5 equivalents unlabeled ligand in H2O.
See Materials and Methods for details.
b This spectrum was recorded at an elevated temperature for better relaxation properties. 1H-13C HSQC
spectra showed that ribose 1H and 13C chemical shifts remained largely unchanged after heating from
293 to 303 K.
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Table 2: Structure statistics.
Completeness of resonance assignments:
—Protein, backbonea 89.0% (445/500)
—Protein, all atomsb 83.5% (1117/1338)
—c-di-GMPc 83.3% (50/60)
Distance constraintsd:
—Protein, intraresidue (i = j) 106
—Protein, sequential (|i - j| = 1) 367
—Protein, short range (2 ! |i - j| ! 5) 213
—Protein, long range (|i - j| " 6) 379
—Protein to ligand 29
—Within ligand 56
—Total 1150
—NOE constraints per residue 9.20
RDCs, protein 154
RDCs, c-di-GMP 11
Hydrogen bonds 53
TALOS torsion angle constraints20 128
&1 angle constraints
e 25
Total number of constraints 1521
Total constraints per residue 12.17
Number of structures calculated / used 60/10
Constraint violations:
—Average number of distance violations >0.1 Å per structure 193
—RMSD of distance violations f 0.21 Å
—RMSD of dihedral angle violations 4.1°
—RMSD of RDC violations 1.44 Hz
Coordinate precision  (RMSD to average):
—Protein backbone atoms,g ! barrel h 0.34 Å
—Protein backbone atoms,g residues F38-N127 0.53 Å
—All non-hydrogen atoms, residues F38-N127 0.97 Å
—c-di-GMP non-hydrogen atoms 1.98 Å
Ramachandran plot summary from PROCHECK-NMR38,i
—Most favored regions 82.6%
—Additionally allowed regions 13.6%
—Generously allowed regions 3.8%
—Disallowed regions 0.0%
a Considering 1HN, 15N (except Pro), 13C%, and 1H% resonances of residues M23-D147.
b Considering routinely assignable 1H, 15N, and 13C resonances of residues M23-D147, excluding N-
terminal and Lys amino groups, Arg guanidino groups, hydroxyl protons of Ser, Thr, Tyr, thiol protons
of Cys, carboxyl resonances of Asp and Glu, nonprotonated aromatic carbons, and Pro 15N. 1H
belonging to the same methyl group and Phe, Tyr 1H#, 1H$ are counted as one.
c Considering H1', C1', H2', C2', H3', C3', H4', C4', H5', H5'', C5', H1, N1, H8, C8.
d Conformationally restricting restraints, i.e. excluding distances between geminal hydrogens or protons
of the same aromatic group.
e Derived from H%-H! 3J coupling constants and HN-H! ROE distances.
f NOEs and hydrogen bonds.
g NH, C%, and C'.
h Residues D41-Q46, R49-V58, G62-G66, P78-Y84, L90-R101, L104-I112.
i Residues F38-N127 and L138-L141, excluding Gly and Pro).
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Figure 1: C-di-GMP. (a) Chemical structure. (b) Crystal structure.6
Figure 2: Secondary 13C% and 13C! shifts for free PA4608 and PA4608 · c-di-
GMP. The secondary structure found in free PA4608 is indicated, with arrows
representing ! sheet and spirals representing % and 310 helices. Residues M3-H22
form the His tag and linker and are shown in gray / pale colors. See text for
details.
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Figure 3: Excerpt from a 2D 1H-1H NOESY spectrum of PA4608 with bound c-
di-GMP. The spectral region shown contains 1H atoms with extraordinarily high
chemical shifts on the horizontal axis. Peaks are labeled where assignments are
known.
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Figure 4: Intra-c-di-GMP and c-di-GMP to protein NOEs. C-di-GMP is shown
as sticks; protein residues contacting the ligand are shown as balls and sticks.
Protein side chains are only shown where necessary. NOE distance constraints
are shown as orange lines. The figure was prepared with VMD-XPLOR.39
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Figure 5: Overlay of the 10 lowest energy models out of 60 calculated,
illustrating the precision of the structure (see also Table 2). Secondary structure
elements and coils of PA4608 are shown in blue and gray, respectively. The two
molecules of c-di-GMP are shown as green/CPK and cyan/CPK sticks.
Hydrogen atoms were omitted for clarity. Parts of the protein C terminus are not
shown.
Figure 6: Structure of PA4608 with bound c-di-GMP. Left: view emphasizing
the arrangement of secondary structure elements; right: view revealing the
intercalated c-di-GMP dimer. Colors are as in Figure 5.
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Figure 7: Overlay of free PA4608 (PDB 1YWU11 model 12; yellow) with
PA4608 · c-di-GMP (blue). Figures 5 and 6 were prepared with MacPyMol.40
Figure 8: amide 15N relaxation data for PA4608 with (red) and without (black)
bound c-di-GMP at 293 K.
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